Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.0015861483013572706,1.8119192254853886,11.68044062774283,"['PRKAA1', 'SHC3', 'THRB', 'MAPKAP1', 'PIK3R4', 'SLC2A1', 'PRKAG2', 'CBLB', 'PIK3R1', 'FOXO3', 'PIK3C2A', 'CBL', 'RPTOR', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'MAPK8', 'RPS6KA5', 'AKT2', 'MAP3K9', 'MAP3K7', 'MAP3K4', 'MAP2K5', 'MAPK4', 'MAPK3', 'MAP4K4', 'MAP2K3', 'MAP3K2', 'MAP3K3', 'PTPN1', 'PRKAB2', 'MAP2K1', 'MAP3K1', 'PDPK1', 'INSR', 'DIO2', 'MAPK14', 'MLXIPL', 'RPS6KB1', 'RHEB', 'SCD', 'RAPGEF1', 'PIK3C3', 'RAF1', 'MAP3K13', 'MAP3K14', 'RHOQ']",0.5327961257081526,0,0,47
2,Cardiac Hypertrophic Response WP2795,0.0018532039155066179,2.4704163294667745,15.540992111991633,"['MAP2K3', 'HDAC4', 'MAP2K1', 'CAMK2D', 'MAP3K1', 'CHUK', 'PDPK1', 'MAPK14', 'FGF2', 'HDAC9', 'TGFBR1', 'HDAC7', 'IKBKB', 'CDK9', 'MAPK8', 'AKT2', 'PRKD1', 'RAF1', 'CALM1', 'MAP3K7', 'MAP3K14', 'MAP2K5', 'MAPK3']",0.5327961257081526,0,0,23
3,Autophagy WP4923,0.0038095127296421255,2.971425613417538,16.55159538062736,"['BECN1', 'PRKAA1', 'PRKAB2', 'ATG9A', 'PIK3R4', 'PRKAG2', 'AMBRA1', 'ATG13', 'RPTOR', 'MAP1LC3B', 'DEPTOR', 'AKT1S1', 'PIK3C3', 'ATG7', 'ATG5']",0.5729868834658227,0,0,15
4,Glycogen Synthesis and Degradation WP500,0.004219674683602668,2.575969827586207,14.085395915548672,"['GBE1', 'AGL', 'PPP2R2A', 'PHKB', 'PPP2R5D', 'PPP2R5C', 'PHKA2', 'HK1', 'PPP2CA', 'PTPA', 'GYS1', 'PHKG1', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'GYG2', 'CALM1', 'PGM1']",0.5729868834658227,0,0,18
5,Interleukin-11 Signaling Pathway WP2332,0.006093087171647436,2.4401372504537204,12.446165038077337,"['ATF1', 'MAP2K1', 'CHUK', 'PDPK1', 'RPS6', 'PIK3R1', 'TYK2', 'RUNX2', 'IKBKB', 'PTPA', 'RPS6KB1', 'BGLAP', 'FES', 'FYN', 'GRB2', 'RAF1', 'JAK1', 'MAPK3']",0.5729868834658227,0,0,18
6,Pathways in clear cell renal cell carcinoma WP4018,0.006870430052324054,1.8864205669083718,9.395371540059193,"['SETD2', 'BHLHE41', 'SLC2A1', 'PDGFB', 'ENO1', 'ENO2', 'SDSL', 'HK1', 'RPTOR', 'LDHB', 'LDHA', 'DEPTOR', 'GRB10', 'EP300', 'CEP290', 'PGM1', 'PSPH', 'PDGFRA', 'TGFB2', 'MDH1', 'ARNT', 'ACLY', 'TOX2', 'PKM', 'RHEB', 'AKT1S1', 'GAPDH', 'PFKM', 'PFKP', 'BAP1']",0.5729868834658227,0,0,30
7,Insulin Signaling WP481,0.006975492494366537,1.5605741197577931,7.748800365485239,"['SLC2A1', 'CBLB', 'PIK3C2A', 'IKBKB', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'RPS6KA5', 'GRB14', 'AKT2', 'GRB10', 'ENPP1', 'MAP3K9', 'MAP3K7', 'MAP3K4', 'MAP2K3', 'MAP2K1', 'PDPK1', 'INPP4A', 'RAPGEF1', 'PIK3C3', 'RAF1', 'SGK1', 'RHOQ', 'ARF6', 'PRKAA1', 'SHC3', 'STXBP3', 'STXBP4', 'PIK3R4', 'PIK3R1', 'FOXO3', 'CBL', 'CYTH3', 'MAPK8', 'MAP2K5', 'MAPK4', 'MAPK3', 'MAP4K4', 'MAP3K2', 'MAP3K3', 'PTPN1', 'RAB4A', 'JUN', 'MAP3K1', 'INSR', 'SORBS1', 'MAPK14', 'MYO1C', 'RPS6KB1', 'RHEB', 'GRB2', 'MAP3K13', 'MAP3K14', 'PFKM']",0.5729868834658227,0,0,55
8,Glycolysis and Gluconeogenesis WP534,0.008737294174296866,2.5746971736204576,12.204462981450474,"['MDH1', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'ENO2', 'HK1', 'LDHB', 'LDHA', 'PKM', 'PC', 'DLD', 'PFKM', 'GAPDH', 'PFKP']",0.6279930187775873,0,0,15
9,Fragile X Syndrome  WP4549,0.012853428017001317,1.5763549767890517,6.863677717107976,"['CYFIP2', 'GRIA1', 'EIF4A1', 'ABCD3', 'CLTC', 'TECR', 'ITPR1', 'AP2A1', 'GPHN', 'GRM1', 'RPTOR', 'GRIN2A', 'DEPTOR', 'FYN', 'PRKACA', 'GABRD', 'SH3GL1', 'EPHA4', 'GABRA1', 'NTRK2', 'CPT1A', 'MAP2K1', 'DUSP3', 'HOMER1', 'CDKN2A', 'DICER1', 'AP2B1', 'TARBP2', 'DNM2', 'PPP1CA', 'ALDH3A2', 'RPS6KB1', 'DLG4', 'RHEB', 'MAP1B', 'TBC1D7', 'AKT1S1', 'NF1', 'GRB2', 'RAF1', 'PLCB1', 'EIF4G1', 'SHANK1', 'HCN1']",0.6481796126420715,0,0,44
10,Circadian rhythm related genes WP3594,0.013008587379402964,1.4985257467794588,6.506816935835982,"['KDM5A', 'CHRM1', 'BHLHE41', 'RORA', 'AHR', 'CCAR2', 'PPP1CC', 'NAGLU', 'EP300', 'PRKG2', 'BTRC', 'CHRNB2', 'KLF10', 'CPT1A', 'KCNH7', 'ARNT', 'PROX1', 'ADORA2A', 'PSPC1', 'KCNMA1', 'TOP1', 'PPARA', 'CLOCK', 'DDX5', 'NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'HDAC3', 'KMT2A', 'CIPC', 'CREM', 'RBM4B', 'ARNTL2', 'NPAS2', 'ARNTL', 'MAPK8', 'JUN', 'JUND', 'HOMER1', 'NONO', 'NTRK3', 'GFPT1', 'BTBD9', 'NR2F6', 'PPP1CA', 'SETX', 'PER2', 'STAR', 'BHLHE40', 'ID4', 'GHRL', 'LGR4', 'EZH2']",0.6481796126420715,0,0,54
11,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.013167748405382559,1.8038897893030794,7.810815263475679,"['HDAC4', 'CAMK2D', 'ROCK1', 'PIK3R1', 'FGF2', 'HDAC9', 'HDAC7', 'LRP6', 'IKBKB', 'PPP3CB', 'MAPK8', 'AKT2', 'DVL1', 'MAP2K5', 'MAPK4', 'MAPK3', 'MAP2K3', 'MAP2K1', 'MYEF2', 'CHUK', 'PDPK1', 'MAPK14', 'AGT', 'CDK9', 'RAF1', 'CALM1', 'PLCB2', 'MAP3K14']",0.6481796126420715,0,0,28
12,NRF2 pathway WP2884,0.01367153816469296,1.6855644355644355,7.235182711346543,"['HSP90AB1', 'SRXN1', 'GSTP1', 'PDGFB', 'SLC2A1', 'KEAP1', 'MGST2', 'SLC7A11', 'SLC2A6', 'SLC2A8', 'DNAJB1', 'FTH1', 'PRDX1', 'SLC39A6', 'SLC39A7', 'SLC39A1', 'GSTM4', 'GSTM3', 'CBR1', 'TGFB2', 'HSP90AA1', 'SLC6A17', 'GPX3', 'SLC6A15', 'ABCC5', 'SLC2A13', 'SLC39A11', 'SLC2A9', 'SLC6A6', 'SLC5A8', 'BLVRB', 'FTL', 'NFE2L2', 'HBEGF']",0.6481796126420715,0,0,34
13,Computational Model of Aerobic Glycolysis WP4629,0.014654495590168572,4.501208702659146,19.008640920813438,"['LDHA', 'PKM', 'SLC2A1', 'ENO1', 'GAPDH', 'PFKM', 'HK1']",0.6481796126420715,0,0,7
14,Proteoglycan biosynthesis WP4784,0.0163105140260327,3.3077513725189083,13.614523870227375,"['EXT1', 'EXT2', 'CHSY1', 'B3GAT3', 'IMPAD1', 'XYLT1', 'B3GALT6', 'EXTL3', 'PAPSS2']",0.6698961117834858,0,0,9
15,Thiamine metabolic pathways WP4297,0.017926262042626075,5.1433941997851775,20.684100564370425,"['BCKDHA', 'TPK1', 'SLC19A3', 'OGDH', 'TKT', 'SLC19A2']",0.6871733783006663,0,0,6
16,Splicing factor NOVA regulated synaptic proteins WP4148,0.021203593096114397,2.0149222263868065,7.764673314188821,"['GABBR2', 'CADM3', 'KCNJ6', 'CASK', 'GRIK2', 'ATP2B1', 'ANK3', 'GPHN', 'DAB1', 'CDH2', 'EPB41L3', 'KCNMA1', 'TERF2IP', 'NCDN', 'STX2', 'CAMK2G', 'MAPK4', 'CLASP1']",0.730995508690493,0,0,18
17,Tgif disruption of Shh signaling WP3674,0.021995702096453167,inf,inf,"['SMAD2', 'TGIF1', 'FOXG1']",0.730995508690493,0,0,3
18,Mesodermal commitment pathway WP2857,0.022883337663354566,1.563449681053655,5.90569078387355,"['YAP1', 'SETD2', 'CTBP2', 'NCAPG2', 'CHRD', 'HTT', 'MBTD1', 'PPP2CA', 'EPB41L5', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'PRKACA', 'KDM6A', 'ACVR1', 'SMAD2', 'ATP8B2', 'TET1', 'ELP4', 'TRERF1', 'EMSY', 'ACVR2A', 'PARP8', 'EXT1', 'LATS1', 'EXT2', 'MEIS1', 'KLF5', 'AEBP2', 'BHLHE40', 'NABP2', 'TCF4', 'WDFY2', 'BMPR1A', 'NFE2L2', 'CUL4B']",0.730995508690493,0,0,37
19,Ferroptosis WP4313,0.02421134150515827,2.144908030506954,7.981061428574647,"['PRNP', 'TFRC', 'ACSL5', 'SAT2', 'SLC7A11', 'MAP1LC3B', 'TF', 'FTH1', 'PCBP1', 'PCBP2', 'VDAC3', 'VDAC2', 'ATG7', 'ATG5', 'FTL']",0.7327116508140002,0,0,15
20,miRNAs involved in DNA damage response WP1545,0.026747831854243214,3.600590921300027,13.038826604373815,"['RAD52', 'CDKN1A', 'CCND3', 'CDK6', 'H2AFX', 'ABL1', 'ATM']",0.7364334815745358,0,0,7
21,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.034285079746627915,3.857142857142857,13.010316475847434,"['GRM3', 'GABBR2', 'GPRC5B', 'GRM4', 'GRM7', 'GRM1']",0.7364334815745358,0,0,6
22,Osteopontin Signaling WP1434,0.034285079746627915,3.857142857142857,13.010316475847434,"['IKBKB', 'MAP2K1', 'CHUK', 'SPP1', 'MAP3K14', 'MAPK3']",0.7364334815745358,0,0,6
23,Histone Modifications WP2369,0.0346004737337597,1.9024695839529737,6.399694423632052,"['KMT2E', 'SETD2', 'KMT2A', 'SETD6', 'KMT2C', 'SETD7', 'DOT1L', 'KMT2B', 'SETD1A', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'AEBP2', 'NSD1', 'SMYD2', 'EZH2']",0.7364334815745358,0,0,17
24,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.0346004737337597,1.9024695839529737,6.399694423632052,"['BECN1', 'PRKAA1', 'PIK3R4', 'WDR45', 'GTPBP2', 'ATG13', 'RPTOR', 'DCAF17', 'DEPTOR', 'SCP2', 'RHEB', 'AKT1S1', 'PIK3C3', 'ATG4A', 'ATG7', 'ATG5', 'FTL']",0.7364334815745358,0,0,17
25,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.03957892107730469,2.5721580220370868,8.306677840889163,"['NQO2', 'JUN', 'MAPK8', 'SRXN1', 'GSTP1', 'EPHX1', 'KEAP1', 'MAPK14', 'NFE2L2']",0.7364334815745358,0,0,9
26,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.03975715897089337,1.4115609327335712,4.552235103409623,"['GRIA1', 'GABRB3', 'PRKAA1', 'SHC3', 'DOCK3', 'PIK3R1', 'FOXO3', 'IKBKB', 'PPP2CA', 'RPS6KA3', 'MAPK8', 'RPS6KA5', 'CDH2', 'RACK1', 'SPP1', 'KCNN2', 'FYN', 'MAP2K5', 'GRIA3', 'NCK1', 'MAPK3', 'NSF', 'MAP3K2', 'NTRK2', 'MAP2K1', 'JUN', 'MAP3K1', 'CHUK', 'PDPK1', 'KIDINS220', 'SORT1', 'BAD', 'NTRK3', 'RPS6', 'RANBP9', 'FRS2', 'EEF2', 'MAPK14', 'VAV2', 'TIAM1', 'DLG1', 'CDK5', 'RPS6KB1', 'GRB2', 'RAF1', 'CDK5R1']",0.7364334815745358,0,0,46
27,G13 Signaling Pathway WP524,0.04097192673785319,2.001375433560579,6.394130649914034,"['ROCK1', 'TNK2', 'LIMK1', 'ARHGDIG', 'IQGAP1', 'SH3RF1', 'RPS6KB1', 'CFL2', 'PIP4K2A', 'ARHGEF1', 'PAK3', 'PFN1', 'CALM1', 'MAP3K4']",0.7364334815745358,0,0,14
28,Integrin-mediated Cell Adhesion WP185,0.04125038281204997,1.5454054054054054,4.926899069696151,"['ITGB1', 'SHC3', 'ROCK1', 'ILK', 'RAP1B', 'CAPNS1', 'AKT2', 'CAPN2', 'CAPN3', 'ITGB8', 'FYN', 'PAK3', 'PAK2', 'MAP2K5', 'MAPK4', 'TNS1', 'MAP2K3', 'GIT2', 'MAP2K1', 'PDPK1', 'SORBS1', 'VAV2', 'SELENOP', 'RAPGEF1', 'ZYX', 'ITGA7', 'GRB2', 'RAF1', 'ARHGEF7', 'VCL']",0.7364334815745358,0,0,30
29,"GPCRs, Other WP117",0.042333791479986324,1.9300134589502018,6.103030001138455,"['CHRM3', 'HTR1F', 'GPR88', 'OR2M4', 'GPR83', 'CELSR2', 'GRM1', 'CELSR3', 'GPR162', 'GPR176', 'ADORA2A', 'FSHR', 'ADGRL2', 'GPR135', 'ADGRL3']",0.7364334815745358,0,0,15
30,Regulation of Actin Cytoskeleton WP51,0.04260031548184456,1.4207437079690945,4.483716003715979,"['CYFIP2', 'CHRM3', 'CHRM1', 'ROCK1', 'CHRM5', 'PDGFB', 'PIK3R4', 'IQGAP1', 'PIK3R1', 'PIK3C2A', 'FGF2', 'ACTB', 'FGD1', 'PIK3C2B', 'FGF5', 'FGF9', 'CFL2', 'PIP4K2A', 'PIP4K2C', 'PAK3', 'MYH10', 'PAK2', 'WASF2', 'GIT1', 'MAPK4', 'MAPK3', 'APC2', 'PDGFRA', 'MAP2K1', 'GSN', 'LIMK1', 'RRAS2', 'SSH2', 'SSH1', 'DIAPH3', 'ARHGEF4', 'PIK3C3', 'ARHGEF1', 'PFN1', 'EZR', 'RAF1', 'ARHGEF7', 'VCL']",0.7364334815745358,0,0,43
31,NLR Proteins WP288,0.04388764837650271,4.285011185682326,13.395469266082005,"['IKBKB', 'MAPK8', 'CHUK', 'ERBIN', 'MAP3K7']",0.7364334815745358,0,0,5
32,Cori Cycle WP1946,0.044163060392349844,3.000179067060614,9.360158396492261,"['LDHA', 'PGAM1', 'SLC2A1', 'GPT', 'GAPDH', 'PFKP', 'HK1']",0.7364334815745358,0,0,7
33,Type II diabetes mellitus WP1584,0.044163060392349844,3.000179067060614,9.360158396492261,"['IKBKB', 'SURF1', 'MAPK8', 'KCNJ11', 'INSR', 'CACNA1A', 'PHKA2']",0.7364334815745358,0,0,7
34,Kit receptor signaling pathway WP304,0.044882843813585,1.7466220117796512,5.42099013527956,"['MAP2K1', 'BAD', 'RPS6', 'GAB2', 'PIK3R1', 'FOXO3', 'CBL', 'MAPK14', 'RPS6KA3', 'MAPK8', 'TEC', 'RPS6KB1', 'GRB10', 'EP300', 'FYN', 'GRB2', 'RAF1', 'JUNB', 'MAPK3']",0.7364334815745358,0,0,19
35,TGF-beta Signaling Pathway WP366,0.04663734884961021,1.435499477493517,4.400313464436369,"['ITGB1', 'YAP1', 'CDKN1A', 'ROCK1', 'ZFYVE9', 'PIK3R1', 'MAPK8', 'PRKAR2A', 'EP300', 'BTRC', 'MAP3K7', 'JUNB', 'PAK2', 'RNF111', 'MAPK4', 'NUP214', 'MAP2K3', 'SMAD2', 'TGIF1', 'KLF10', 'TRAP1', 'KLF11', 'MAP2K1', 'JUN', 'JUND', 'SMURF1', 'LIMK2', 'MAPK14', 'PIAS2', 'RUNX2', 'TGFBR1', 'PJA1', 'ZEB2', 'ITCH', 'ZFYVE16', 'FOSB', 'GRB2', 'RAF1', 'DCP1A']",0.7364334815745358,0,0,39
36,Aryl Hydrocarbon Receptor Pathway WP2873,0.04738789359697013,2.176701760191946,6.637609298590183,"['HSP90AA1', 'JUN', 'JUND', 'AIP', 'EP300', 'CYP1B1', 'ARNT', 'AHR', 'POLK', 'JUNB', 'NFE2L2']",0.7364334815745358,0,0,11
37,Sphingolipid pathway WP1422,0.04738789359697013,2.176701760191946,6.637609298590183,"['PPP2CA', 'UGCG', 'CERS4', 'CERS5', 'CERS6', 'SGMS1', 'SERINC1', 'KDSR', 'SGPP2', 'PPP1CA', 'CERS2']",0.7364334815745358,0,0,11
38,Insulin signaling in adipocytes (diabetic condition) WP3635,0.0558353325579003,5.141170155662909,14.834067134279168,"['RPS6KB1', 'INSR', 'AKT2', 'RPS6']",0.7646066920135708,0,0,4
39,Insulin signaling in adipocytes (normal condition) WP3634,0.0558353325579003,5.141170155662909,14.834067134279168,"['RPS6KB1', 'INSR', 'AKT2', 'RPS6']",0.7646066920135708,0,0,4
40,Canonical and non-canonical Notch signaling WP3845,0.05695907651089416,2.3147003493684495,6.632593825181298,"['NOTCH2', 'HEY1', 'CHUK', 'MFAP1', 'MAML1', 'CNTN6', 'ADAM10', 'PSEN1', 'MAML3']",0.7646066920135708,0,0,9
41,Glycolysis in senescence WP5049,0.057841807883120336,3.085392051557465,8.793501391785071,"['LDHA', 'PRKAA1', 'PKM', 'ENO1', 'GAPDH', 'HK1']",0.7646066920135708,0,0,6
42,Vitamin D Receptor Pathway WP2877,0.059893723478212015,1.5112188707158707,4.254358524460596,"['CEBPA', 'CDKN1A', 'HILPDA', 'CLEC16A', 'GXYLT2', 'ASAP2', 'TRAK1', 'CYP3A5', 'CRACR2A', 'BGLAP', 'TIMP2', 'SPP1', 'SOSTDC1', 'JUNB', 'TGFB2', 'GADD45A', 'CDKN2A', 'IGFBP3', 'CDKAL1', 'MYO9B', 'STAM', 'ATP2B1', 'CEACAM1', 'ID4', 'IGSF9B', 'ZNF257', 'HLA-DRB1']",0.7646066920135708,0,0,27
43,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06049963372213826,1.2028145787355287,3.3740367871556263,"['EPRS', 'GJA1', 'RPS6KA5', 'BSG', 'GRB10', 'CAPN2', 'RPS11', 'IER5', 'MAP2K3', 'ACOT9', 'MAP2K1', 'IGFBP3', 'RPS6', 'ADAM10', 'FRS2', 'SND1', 'ARMCX1', 'EWSR1', 'RAB37', 'NCL', 'MAPKAPK2', 'ADAM9', 'PRKD1', 'PFN1', 'EZR', 'ATP6V0D1', 'RAF1', 'ATF6', 'VCL', 'CNP', 'MAPKAP1', 'IQGAP1', 'PIK3R1', 'FOXO3', 'GIGYF2', 'RAP1B', 'LDHA', 'MYO6', 'ABL1', 'TXNDC5', 'JUN', 'RAB4A', 'PRRC2C', 'TRIP4', 'MICAL2', 'STAM', 'SMARCA2', 'QKI', 'NR4A1', 'P4HA2', 'SPIRE1', 'TPP1', 'GRB2', 'EIF4G1', 'ITGB1', 'ARF4', 'KCNC3', 'FAF1', 'CLTC', 'NRARP', 'AP2A1', 'LDB2', 'SHB', 'HERPUD1', 'RACK1', 'SH3BGRL3', 'LRRFIP2', 'NCK1', 'HSP90AA1', 'SSR4', 'PDPK1', 'TRPC1', 'ARNT', 'EPN1', 'VAV2', 'AKT1S1', 'RAPGEF1', 'MYH9', 'TKT', 'GAPDH', 'FJX1', 'ARF6', 'HBEGF', 'HDAC4', 'KANK1', 'PRKAA1', 'ROCK1', 'PTGS2', 'CBL', 'SLC7A1', 'HDAC9', 'APOLD1', 'HDAC7', 'PPP2CA', 'MAPK8', 'FAM120A', 'DNAJB9', 'FLNB', 'FYN', 'PAK2', 'BRD4', 'MAPK3', 'PTPN1', 'RBM39', 'LIMK1', 'PDE4DIP', 'SOD2', 'MAPK14', 'TPCN2', 'RAB11A', 'PPP1CA', 'ITCH', 'MYO1C', 'RPS6KB1', 'PTPN9', 'COPG1']",0.7646066920135708,0,0,116
44,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.06093634509541492,2.14336917562724,5.996987235286936,"['PPP2CA', 'CDKN1A', 'MAP2K1', 'CNP', 'FGF9', 'SOX9', 'MAPK14', 'RAF1', 'ATG5', 'MAPK3']",0.7646066920135708,0,0,10
45,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.06581649774421669,1.92926304464766,5.249302390131844,"['HDAC4', 'CDK9', 'PPP3CB', 'HDAC3', 'PPP3CC', 'NFATC3', 'EP300', 'NELFB', 'HDAC8', 'SUPT5H', 'HDAC9', 'HDAC7']",0.7646066920135708,0,0,12
46,IL-2 signaling pathway WP49,0.06716629687527267,1.857920066959615,5.01746863360636,"['MAP2K1', 'JUN', 'RPS6', 'PIK3R1', 'GAB2', 'FOXO3', 'CBL', 'RPS6KB1', 'FYN', 'GRB2', 'RAF1', 'JAK1', 'MAPK3']",0.7646066920135708,0,0,13
47,Sulindac Metabolic Pathway WP2542,0.06950143822270026,7.71049101153743,20.55931362769464,"['MSRA', 'CYP1B1', 'MSRB3']",0.7646066920135708,0,0,3
48,Vitamin B6-dependent and responsive disorders WP4228,0.06950143822270026,7.71049101153743,20.55931362769464,"['PNPO', 'PIGV', 'AASS']",0.7646066920135708,0,0,3
49,EGF/EGFR signaling pathway WP437,0.07169690034956024,1.3146073646850045,3.4643949936354725,"['ATF1', 'SH3KBP1', 'CBLB', 'AP2A1', 'PIK3C2B', 'RPS6KA3', 'GJA1', 'RPS6KA5', 'GRB10', 'MAP3K4', 'NCK1', 'JAK1', 'MAP2K1', 'PDPK1', 'NCOA3', 'EPS15L1', 'GAB2', 'EPN1', 'VAV2', 'RASA1', 'ARHGEF1', 'RAF1', 'STAM2', 'ARF6', 'ROCK1', 'ASAP1', 'IQGAP1', 'PIK3R1', 'CBL', 'PLD2', 'MAPK8', 'ABL1', 'REPS2', 'MAP2K5', 'MAPK4', 'MAP3K2', 'MAP3K3', 'JUN', 'JUND', 'MAP3K1', 'TNK2', 'LIMK2', 'STAM', 'PTPN12', 'AP2B1', 'MAPK14', 'ITCH', 'RPS6KB1', 'FOSB', 'GRB2']",0.7646066920135708,0,0,50
50,Ebstein-Barr virus LMP1 signaling WP262,0.07406116128529988,2.2857484028897246,5.949492284171485,"['IKBKB', 'MAP3K3', 'HSP90AA1', 'MAPK8', 'CHUK', 'MAP3K7', 'MAP3K14', 'PDLIM7']",0.7646066920135708,0,0,8
51,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.07406116128529988,2.2857484028897246,5.949492284171485,"['SMAD2', 'MAPK8', 'NR2C2', 'MAPK14', 'TGFBR1', 'RUNX2', 'MAPK3', 'FBN1']",0.7646066920135708,0,0,8
52,Biotin Metabolism (including IEMs) WP5031,0.07633941393403075,3.2134228187919462,8.266741994004718,"['BTD', 'PC', 'PCCA', 'HLCS', 'MCCC1']",0.7646066920135708,0,0,5
53,Neuroinflammation WP4919,0.07633941393403075,3.2134228187919462,8.266741994004718,"['JUN', 'MAPK8', 'CHUK', 'ASCC1', 'MAPK14']",0.7646066920135708,0,0,5
54,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.07857476928933303,2.104053162639564,5.352089776805041,"['RPS6KB1', 'RHEB', 'FSHR', 'RPS6', 'PRKACA', 'MAPK14', 'SGK1', 'RAF1', 'MAPK3']",0.7646066920135708,0,0,9
55,TNF-alpha signaling pathway WP231,0.07917993169077465,1.4415991356023772,3.6559421157177847,"['TANK', 'IKBKB', 'PPP2CA', 'MAPK8', 'TBK1', 'PSMD2', 'RFK', 'BTRC', 'RFFL', 'MAP3K7', 'GLUL', 'MAPK3', 'MAP2K3', 'TRAP1', 'MAP3K3', 'HSP90AA1', 'JUN', 'MAP3K1', 'CHUK', 'BAD', 'KSR2', 'CFLAR', 'GRB2', 'TAB2', 'RAF1', 'NFKBIE', 'MAP3K14', 'NSMAF']",0.7646066920135708,0,0,28
56,Pathways affected in adenoid cystic carcinoma WP3651,0.07989543129539532,1.5595850690190314,3.9411285629004187,"['MAGI1', 'CEBPA', 'SETD2', 'CNTN6', 'KMT2C', 'MGA', 'ERBIN', 'JMJD1C', 'ARID4B', 'FOXO3', 'SMARCA2', 'MORF4L1', 'KANSL1', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'RAF1', 'KDM6A']",0.7646066920135708,0,0,20
57,Signal transduction through IL1R WP4496,0.08158750676593253,1.978287841191067,4.957745876080782,"['IKBKB', 'MAP2K3', 'MAPK8', 'TGFB2', 'JUN', 'MAP3K1', 'CHUK', 'MAPK14', 'MAP3K7', 'MAP3K14']",0.7646066920135708,0,0,10
58,Rett syndrome causing genes WP4312,0.0822786664622941,1.5970384958382877,3.9888326932389373,"['KDM5B', 'SRRM3', 'GABBR2', 'EIF2B2', 'FOXG1', 'HTT', 'HDAC8', 'SMARCA1', 'SMARCA2', 'CECR2', 'XAB2', 'GRIN2A', 'TAF1B', 'IMPDH2', 'TCF4', 'HIVEP2', 'SCN2A', 'GABRD']",0.7646066920135708,0,0,18
59,Interferon type I signaling pathways WP585,0.08328974036269957,1.6199439407088208,4.0262571103008975,"['MAP2K3', 'EIF4A1', 'MAP3K1', 'MAPKAP1', 'RPS6', 'TYK2', 'GAB2', 'PIK3R1', 'CBL', 'MAPK14', 'RPTOR', 'RPS6KA5', 'RPS6KB1', 'RACK1', 'RAPGEF1', 'FYN', 'JAK1']",0.7646066920135708,0,0,17
60,Pathogenic Escherichia coli infection WP2272,0.0841323660373904,1.6465266558966074,4.075752700750979,"['ITGB1', 'ROCK1', 'TUBB', 'ARPC1A', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA1B', 'CTTN', 'ARPC2', 'TUBB3', 'NCL', 'ABL1', 'FYN', 'EZR', 'NCK1']",0.7646066920135708,0,0,16
61,PDGF Pathway WP2526,0.08475800175482544,1.6777459184270584,4.140601631441614,"['MAP2K1', 'JUN', 'MAP3K1', 'CHUK', 'PDGFB', 'PIK3R1', 'VAV2', 'TIAM1', 'MAPK8', 'RASA1', 'ARFIP2', 'GRB2', 'RAF1', 'JAK1', 'MAPK3']",0.7646066920135708,0,0,15
62,Disruption of postsynaptic signaling by CNV WP4875,0.08508876945476032,1.759950724268298,4.33662457044126,"['NLGN1', 'CAMK2D', 'HOMER1', 'NRXN3', 'GRM1', 'GRIN2A', 'DLG1', 'DLG2', 'DLGAP1', 'CAMK2G', 'YWHAG', 'MAPK3', 'SHANK1']",0.7646066920135708,0,0,13
63,IL-3 signaling pathway WP286,0.08510404919803223,1.7149264442052385,4.225374104154754,"['MAP2K1', 'JUN', 'BAD', 'GAB2', 'PIK3R1', 'CBL', 'MAPK8', 'RAPGEF1', 'FYN', 'GRB2', 'PRKACA', 'RAF1', 'JAK1', 'MAPK3']",0.7646066920135708,0,0,14
64,Netrin-UNC5B signaling pathway WP4747,0.08510404919803223,1.7149264442052385,4.225374104154754,"['YAP1', 'MAP2K1', 'JUN', 'ARHGEF12', 'NTN4', 'MAPK14', 'RLF', 'PPP1CA', 'PTPA', 'PPP2R1B', 'FYN', 'RAF1', 'PLEKHH1', 'MAPK3']",0.7646066920135708,0,0,14
65,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.10187670511528286,1.5830330143738867,3.6156346934440906,"['TGIF1', 'SMAD2', 'JUN', 'ZFYVE9', 'LTBP3', 'SMAD5', 'TGFBR1', 'RUNX2', 'ADAMTS10', 'ZEB2', 'SPP1', 'EP300', 'ZNF423', 'JAK1', 'MAPK3', 'FBN1']",0.9012170067890408,0,0,16
66,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.10573728097085887,1.6717783158461124,3.756147746499268,"['MAP2K3', 'MAP2K1', 'JUN', 'MAP3K1', 'MAPK14', 'RPS6KA3', 'MAPK8', 'IFI27', 'MAP3K9', 'RAF1', 'JUNB', 'MAP3K4', 'MAPK3']",0.9093232345900499,0,0,13
67,CAMKK2  Pathway WP4874,0.1063988070226111,1.7145418683880222,3.8415354962941706,"['HDAC4', 'RPTOR', 'CHRM3', 'MAF', 'STIM1', 'EP300', 'ARHGEF7', 'RAF1', 'CALM1', 'GIT1', 'MAPK3', 'NFE2L2']",0.9093232345900499,0,0,12
68,Nuclear Receptors Meta-Pathway WP2882,0.10753735643847548,1.2287140340575455,2.739930300428195,"['HSP90AB1', 'SRXN1', 'SLC2A1', 'KEAP1', 'SLC7A11', 'AHR', 'SLC2A6', 'SLC2A8', 'RGS2', 'SCP2', 'FTH1', 'SLC39A6', 'CYP1B1', 'EP300', 'SLC39A7', 'POLK', 'JUNB', 'SLC39A1', 'CBR1', 'CPT1A', 'HSP90AA1', 'SLC6A17', 'NCOA6', 'GPX3', 'SLC6A15', 'NCOA3', 'SLC2A13', 'ABCC5', 'SLC39A11', 'AIP', 'ARNT', 'SLC5A8', 'NAV3', 'BLVRB', 'PPARA', 'HBEGF', 'FTL', 'GSTP1', 'ABHD2', 'AMIGO2', 'PDGFB', 'MGST2', 'PTGS2', 'CYP3A5', 'PTPA', 'DNAJB1', 'PRDX1', 'SLC19A2', 'GSTM4', 'GSTM3', 'JUN', 'TGFB2', 'JUND', 'SMARCA1', 'SLC2A9', 'SLC6A6', 'PSMC5', 'GPAM', 'SCD', 'BHLHE40', 'SPRY1', 'NFE2L2']",0.9093232345900499,0,0,62
69,3q29 copy number variation syndrome WP4906,0.11377531490184266,1.4812065685145717,3.219446464537372,"['DYNC2H1', 'GRIA1', 'JUN', 'PCYT1A', 'TFRC', 'MYCBP2', 'ADAM10', 'MAD2L1BP', 'ZNF76', 'DYNLL2', 'RNF168', 'DLG1', 'TF', 'BRINP1', 'WDR60', 'UBXN7', 'FGFR1OP', 'DYNLRB1', 'PAK2']",0.9481276241820222,0,0,19
70,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.12432337787899939,1.5432032301480485,3.217376917657742,"['MAP2K1', 'JUN', 'CHUK', 'CBL', 'MALT1', 'IKBKB', 'DLG1', 'FYN', 'GRB2', 'RAF1', 'CALM1', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.9999812599146137,0,0,15
71,IL-9 signaling pathway WP22,0.1273124642727167,2.2033911308884457,4.541433401088936,"['CDK9', 'MAP2K1', 'GRB2', 'PIK3R1', 'MAPK3', 'JAK1']",0.9999812599146137,0,0,6
72,Phytochemical activity on NRF2 transcriptional activation WP3,0.1273124642727167,2.2033911308884457,4.541433401088936,"['AIMP2', 'MAPK8', 'MAF', 'KEAP1', 'SLC7A11', 'NFE2L2']",0.9999812599146137,0,0,6
73,ATM Signaling Pathway WP2516,0.12910097391116304,1.5920032796546113,3.2590861301719167,"['CDKN1A', 'JUN', 'GADD45A', 'H2AFX', 'AP3B2', 'PIDD1', 'CCNB1', 'ABL1', 'CASP2', 'TLK1', 'MDM4', 'ATM', 'RAD9A']",0.9999812599146137,0,0,13
74,Ectoderm Differentiation WP2858,0.13079874357597368,1.2869518137520304,2.617782823179928,"['NLGN1', 'STX16', 'CTNND2', 'ARHGDIG', 'PRKAG2', 'LDB2', 'CELSR2', 'CDH8', 'ZBTB2', 'WDR44', 'CDH6', 'TRPM2', 'PLXNA2', 'UBTF', 'DMD', 'FYN', 'CTNNA2', 'PGM1', 'CLVS1', 'TTC14', 'BCAS3', 'KCNK10', 'SMURF1', 'GREB1', 'C1GALT1', 'SORCS1', 'SERPINB6', 'PAN2', 'PPFIBP2', 'ZNF219', 'KIFC3', 'PDE7A', 'MYORG', 'TRIM33', 'ASTN1', 'BMPR1A']",0.9999812599146137,0,0,36
75,Physiological and pathological hypertrophy of the heart WP1528,0.134683421051515,1.7799805676720484,3.5685553864678736,"['MAP2K3', 'CAMK2D', 'MAPK8', 'PPP3CB', 'JUN', 'MYEF2', 'MAPK14', 'CALM1', 'AGT']",0.9999812599146137,0,0,9
76,Sphingolipid Metabolism (integrated pathway) WP4726,0.134683421051515,1.7799805676720484,3.5685553864678736,"['UGCG', 'CERS4', 'CERS5', 'CERS6', 'SGMS1', 'DEGS1', 'KDSR', 'SGPP2', 'CERS2']",0.9999812599146137,0,0,9
77,Molybdenum cofactor (Moco) biosynthesis WP4507,0.1379003564231332,3.854843037295412,7.637307193001742,"['MARC2', 'SUOX', 'GPHN']",0.9999812599146137,0,0,3
78,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1379003564231332,3.854843037295412,7.637307193001742,"['NKRF', 'FYN', 'HLA-DRB1']",0.9999812599146137,0,0,3
79,Senescence and Autophagy in Cancer WP615,0.14137664332944058,1.3379049676025918,2.617380575795656,"['BECN1', 'CDKN1A', 'SPARC', 'KMT2A', 'AMBRA1', 'BMI1', 'MAP1LC3B', 'LAMP1', 'LAMP2', 'SLC39A1', 'ATG7', 'ATG5', 'MAP2K3', 'SH3GLB1', 'MAP2K1', 'JUN', 'GSN', 'CDKN2A', 'IGFBP3', 'MAPK14', 'ATG13', 'CDC25B', 'RSL1D1', 'AKT1S1', 'PIK3C3', 'RAF1']",0.9999812599146137,0,0,26
80,Endoderm differentiation WP2853,0.158468330402662,1.2673809744891986,2.3347698824023615,"['CTBP2', 'NCAPG2', 'CDC73', 'MBTD1', 'EPB41L5', 'CAND1', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'MAP2K3', 'SMAD2', 'ATP8B2', 'SFMBT1', 'TET1', 'CDYL', 'FOXN3', 'ELP4', 'TRERF1', 'EMSY', 'PARP8', 'EXT1', 'MAD2L2', 'TNRC6C', 'AEBP2', 'SP4', 'NABP2', 'TCF4', 'WDFY2', 'NAA15', 'EZH2', 'BMPR1A', 'CUL4B']",0.9999812599146137,0,0,33
81,Iron metabolism in placenta WP2007,0.1597421563448728,2.570048309178744,4.713967924705433,"['TF', 'TFRC', 'FTH1', 'ACO1']",0.9999812599146137,0,0,4
82,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.16243625684279686,1.5712407755967852,2.855682374961788,"['MAPK8', 'MAP2K1', 'TEC', 'FES', 'RPS6', 'FYN', 'GAB2', 'MAPK14', 'PI4K2A', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,11
83,Lipid Metabolism Pathway WP3965,0.16581617730389928,1.6068548387096775,2.887318043282537,"['BCKDHA', 'ACLY', 'PRKAA1', 'PRKAB2', 'PRKAR2A', 'AKT2', 'HILPDA', 'PRKAG2', 'ABHD5', 'PRKACA']",0.9999812599146137,0,0,10
84,Exercise-induced Circadian Regulation WP410,0.16774237574436487,1.4188253207806436,2.5330656697670446,"['IDI1', 'GSTM3', 'BTG1', 'GSTP1', 'QKI', 'ARNTL', 'HERPUD1', 'ETV6', 'PER2', 'PSMA4', 'VAPA', 'TUBB3', 'SUMO3', 'TAB2', 'ERC2', 'CLOCK']",0.9999812599146137,0,0,16
85,Sleep regulation WP3591,0.16881651519771204,1.6526663339348102,2.9399989792724104,"['CHRNB2', 'NLGN1', 'GRIN2A', 'AHCY', 'STAR', 'ADORA2A', 'GHRL', 'BTBD9', 'NPAS2']",0.9999812599146137,0,0,9
86,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.168853756710415,2.141834451901566,3.8097286673685695,"['IKBKB', 'MAP3K1', 'CHUK', 'RAF1', 'MAP3K14']",0.9999812599146137,0,0,5
87,NRF2-ARE regulation WP4357,0.17119560041919119,1.7137739566541286,3.0247227982841123,"['AIMP2', 'MAPK8', 'MAF', 'INSR', 'KEAP1', 'FYN', 'SLC7A11', 'NFE2L2']",0.9999812599146137,0,0,8
88,PKC-gamma calcium signaling pathway in ataxia WP4760,0.17119560041919119,1.7137739566541286,3.0247227982841123,"['GRIA1', 'ITPR1', 'CACNA1A', 'CA8', 'PLCB1', 'PLCB2', 'GRM1', 'GRIA3']",0.9999812599146137,0,0,8
89,Signal Transduction of S1P Receptor WP26,0.17119560041919119,1.7137739566541286,3.0247227982841123,"['AKT2', 'GNAI3', 'S1PR3', 'PLCB1', 'PLCB2', 'MAPK4', 'PIK3C2B', 'MAPK3']",0.9999812599146137,0,0,8
90,Urea cycle and associated pathways WP4595,0.17119560041919119,1.7137739566541286,3.0247227982841123,"['SLC25A15', 'LDHB', 'OAT', 'MDH1', 'GOT2', 'GPT', 'SLC25A12', 'SLC25A13']",0.9999812599146137,0,0,8
91,Imatinib and Chronic Myeloid Leukemia WP3640,0.17220923225488732,1.927765843179377,3.3910270119405532,"['PDGFRA', 'GADD45A', 'ABL1', 'GAB2', 'FOXO3', 'SKP2']",0.9999812599146137,0,0,6
92,Prolactin Signaling Pathway WP2037,0.186628153991366,1.3172901774852206,2.211252193836057,"['ITGB1', 'PTPN1', 'MAP2K1', 'JUN', 'RPS6', 'GAB2', 'PIK3R1', 'CBL', 'MAPK14', 'VAV2', 'MAPK8', 'TEC', 'RPS6KB1', 'FYN', 'GRB2', 'RAF1', 'CTSD', 'PPIA', 'YWHAG', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,21
93,MAPK Cascade WP422,0.19487899396982097,1.488388219810079,2.4340750532258855,"['MAP3K2', 'MAP2K3', 'MAP3K3', 'MAP2K1', 'JUN', 'MAP3K1', 'GRB2', 'MAPK14', 'RAF1', 'LAMTOR3', 'MAPK3']",0.9999812599146137,0,0,11
94,Joubert Syndrome WP4656,0.19610279575141434,1.2859455084974374,2.094954774810654,"['BBS2', 'CEP104', 'CEP164', 'CEP120', 'RAB3IP', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'PCM1', 'NIN', 'ARL13B', 'RHEB', 'TMEM237', 'TMEM67', 'DVL1', 'MYO6', 'ANKS6', 'NPHP4', 'ATM', 'ZNF423', 'BBS5', 'CEP290', 'PIBF1']",0.9999812599146137,0,0,23
95,IL-18 signaling pathway WP4754,0.19811652831307394,1.1623439338332133,1.8817184719342201,"['PIGT', 'CD83', 'CD81', 'ZDHHC7', 'ENO1', 'PTMS', 'RPTOR', 'IKBKB', 'ABHD16A', 'GRM7', 'BSG', 'NFKBIZ', 'LONP2', 'LRRFIP1', 'RPS11', 'MAP3K7', 'CPT1A', 'USP5', 'CHUK', 'ECH1', 'TACR1', 'IL17RC', 'TRPC4AP', 'RUNX2', 'LARS2', 'CLDN12', 'KIFC3', 'STK40', 'ARF6', 'PRKAA1', 'HDAC3', 'STOML1', 'MEPCE', 'COX17', 'PIK3R1', 'PTGS2', 'KLC1', 'CENPB', 'TMEM165', 'SPP1', 'TRPM7', 'MAPK3', 'ZNF143', 'JUN', 'BAD', 'FOXN3', 'CFLAR', 'EEF2', 'NR4A1', 'TF', 'UCK1', 'RPS6KB1', 'ZNF219', 'HDGF', 'NFKBIE', 'APBA2']",0.9999812599146137,0,0,56
96,7q11.23 copy number variation syndrome WP4932,0.19830038686049384,1.2432675853372963,2.011572505330254,"['BECN1', 'TSG101', 'HDAC3', 'ELN', 'CLTC', 'UBE2L6', 'ATP5F1A', 'BCL7B', 'WNT2', 'CLASP1', 'CLASP2', 'MAPK3', 'BRD4', 'ATPAF2', 'VPS9D1', 'H2AFX', 'LIMK1', 'UBE2E1', 'SMARCA5', 'VPS37A', 'HSPA2', 'MLXIPL', 'MYO1C', 'OGDH', 'GRB2', 'ERCC6', 'DLD', 'GAPDH', 'FBN1']",0.9999812599146137,0,0,29
97,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.20024302216867673,1.3774274178042685,2.2152111969079558,"['MAP2K3', 'EIF4A1', 'MAP2K1', 'RPS6', 'PIK3R1', 'MAPK14', 'RPTOR', 'MAPK8', 'RPS6KA5', 'RPS6KB1', 'AKT2', 'PRKACA', 'MAP2K5', 'MAPK3', 'EIF4G1']",0.9999812599146137,0,0,15
98,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2006762629158262,1.5121758380771664,2.428648606994455,"['IKBKB', 'MAPK8', 'JUN', 'TBK1', 'CHUK', 'DDX58', 'TYK2', 'MAPK14', 'MAP3K7', 'JAK1']",0.9999812599146137,0,0,10
99,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2006762629158262,1.5121758380771664,2.428648606994455,"['ATF1', 'CREB3', 'CAMK2D', 'STAR', 'CREB3L2', 'ITPR1', 'CALM1', 'CAMK2G', 'PLCB2', 'AGT']",0.9999812599146137,0,0,10
100,Thermogenesis WP4321,0.2111160450037809,1.2248391248391248,1.9050502506984381,"['PRKAA1', 'SMARCD2', 'SMARCD3', 'PRKAG2', 'ACTB', 'ADCY5', 'RPTOR', 'RPS6KA3', 'RPS6KA6', 'CREB3L2', 'PRKG2', 'SLC25A20', 'PRKACA', 'MAP2K3', 'SMARCC1', 'PRKAB2', 'CPT1A', 'RPS6', 'ACTL6A', 'ACSL5', 'FRS2', 'CPT1C', 'MAPK14', 'SMARCA2', 'ARID1B', 'CREB3', 'RPS6KB1', 'RHEB', 'AKT1S1', 'GRB2']",0.9999812599146137,0,0,30
101,Sphingolipid Metabolism (general overview) WP4725,0.21223033771186692,1.5817798536766834,2.451890211957759,"['CERS4', 'UGCG', 'CERS6', 'SGMS1', 'DEGS1', 'KDSR', 'SGPP2', 'CERS2']",0.9999812599146137,0,0,8
102,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.21223033771186692,1.5817798536766834,2.451890211957759,"['P4HA1', 'P4HA2', 'SERPINF1', 'ITPR1', 'P3H2', 'P3H1', 'TMEM38B', 'LRP6']",0.9999812599146137,0,0,8
103,Common Pathways Underlying Drug Addiction WP2636,0.2143470206046331,1.3925656891758587,2.144772559375492,"['GRIA1', 'MAP2K1', 'GRM1', 'ACTB', 'PPP1CA', 'RAP1B', 'PPP1CC', 'GRIN2A', 'PRKACA', 'RAF1', 'CALM1', 'GRIA3', 'MAPK3']",0.9999812599146137,0,0,13
104,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2176808764819801,1.635606671061949,2.493850640034871,"['BECN1', 'PIK3R4', 'PIK3C3', 'ATG4A', 'ATG13', 'ATG7', 'ATG5']",0.9999812599146137,0,0,7
105,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.21996539158255332,2.569627045881406,3.891147835053243,"['HSD11B1', 'H6PD', 'STAR']",0.9999812599146137,0,0,3
106,Glucuronidation WP698,0.21996539158255332,2.569627045881406,3.891147835053243,"['PGM3', 'PGM1', 'HK1']",0.9999812599146137,0,0,3
107,miRNA Biogenesis WP2338,0.21996539158255332,2.569627045881406,3.891147835053243,"['DROSHA', 'DICER1', 'TARBP2']",0.9999812599146137,0,0,3
108,Pilocytic astrocytoma WP2253,0.21996539158255332,2.569627045881406,3.891147835053243,"['NF1', 'GRB2', 'RAF1']",0.9999812599146137,0,0,3
109,NO/cGMP/PKG mediated Neuroprotection WP4008,0.22193371541804477,1.4022201574649127,2.110869302168458,"['GUCY1A2', 'CAMK2D', 'GRIN2A', 'BAD', 'DLG4', 'AKAP9', 'PDE3A', 'NEFL', 'PRKG2', 'CALM1', 'CAMK2G', 'PPID']",0.9999812599146137,0,0,12
110,Proximal tubule transport WP4917,0.22193371541804477,1.4022201574649127,2.110869302168458,"['ATP6V1A', 'ATP6V0B', 'SLC5A8', 'ATP6V0E1', 'CA2', 'SLC2A1', 'SLC3A1', 'SLC16A10', 'ATP1A1', 'ATP1B1', 'ATP6V0C', 'ATP6V1C1']",0.9999812599146137,0,0,12
111,Glycosaminoglycan degradation WP4815,0.22248774360479462,1.713390619405657,2.575026086282967,"['NAGLU', 'IDUA', 'HEXB', 'IDS', 'ARSB', 'SGSH']",0.9999812599146137,0,0,6
112,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.22248774360479462,1.713390619405657,2.575026086282967,"['PECR', 'HADHA', 'ACADVL', 'CPT1A', 'SCP2', 'SLC25A20']",0.9999812599146137,0,0,6
113,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.22248774360479462,1.713390619405657,2.575026086282967,"['ACLY', 'PC', 'MDH1', 'OGDH', 'ACO1', 'DLD']",0.9999812599146137,0,0,6
114,AMP-activated protein kinase (AMPK) signaling WP1403,0.22483800646084945,1.2856372945297763,1.9186530954584116,"['CDKN1A', 'PRKAB2', 'CPT1A', 'PRKAA1', 'INSR', 'PRKAG2', 'PIK3R1', 'CPT1C', 'EEF2', 'ADIPOR2', 'RPTOR', 'GYS1', 'CCNA1', 'CCNB1', 'EEF2K', 'RPS6KB1', 'AKT2', 'PIK3C3', 'PLCB1']",0.9999812599146137,0,0,19
115,Cancer immunotherapy by PD-1 blockade WP4585,0.22593801052534015,1.835666347075743,2.730543791609233,"['NFAT5', 'CD274', 'JUN', 'NFATC3', 'HLA-DRB1']",0.9999812599146137,0,0,5
116,Canonical and non-canonical TGF-B signaling WP3874,0.22593801052534015,1.835666347075743,2.730543791609233,"['SMAD2', 'MAPK8', 'MAPK14', 'TGFBR1', 'BMPR1A']",0.9999812599146137,0,0,5
117,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.22593801052534015,1.835666347075743,2.730543791609233,"['SMAD2', 'CDH6', 'CDH2', 'RUNX2', 'MAPK3']",0.9999812599146137,0,0,5
118,Cytosine methylation WP3585,0.2264643562391582,2.0558239398819107,3.05324334126346,"['DNMT1', 'TET3', 'TET2', 'TET1']",0.9999812599146137,0,0,4
119,Estrogen Receptor Pathway WP2881,0.2264643562391582,2.0558239398819107,3.05324334126346,"['JUN', 'GPAM', 'CYP1B1', 'PPARA']",0.9999812599146137,0,0,4
120,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.2264643562391582,2.0558239398819107,3.05324334126346,"['MAPK8', 'MAP2K1', 'MAFK', 'NFE2L2']",0.9999812599146137,0,0,4
121,Matrix Metalloproteinases WP129,0.2264643562391582,2.0558239398819107,3.05324334126346,"['MMP16', 'BSG', 'TIMP2', 'TCF20']",0.9999812599146137,0,0,4
122,IL-4 signaling pathway WP395,0.22947323389078536,1.3297906901192742,1.9574105183676658,"['CEBPA', 'CHUK', 'BAD', 'TYK2', 'GAB2', 'PIK3R1', 'CBL', 'MAPK14', 'IKBKB', 'RPS6KB1', 'FES', 'EP300', 'GRB2', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,15
123,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.22947323389078536,1.3297906901192742,1.9574105183676658,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'MAPK14', 'TANK', 'IKBKB', 'MAPK8', 'RPS6KA5', 'MAPKAPK2', 'TAB2', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.9999812599146137,0,0,15
124,Synaptic Vesicle Pathway WP2267,0.22947323389078536,1.3297906901192742,1.9574105183676658,"['UNC13B', 'NSF', 'SYT1', 'CLTC', 'CACNA1A', 'AP2A1', 'AP2B1', 'SYN2', 'DNM2', 'DNM3', 'RIMS1', 'STX1B', 'SLC17A7', 'STX2', 'SLC25A4']",0.9999812599146137,0,0,15
125,Target Of Rapamycin (TOR) Signaling WP1471,0.2299149582812512,1.4138209196020435,2.078381483655754,"['RPTOR', 'IDI1', 'PRKAA1', 'PRKAB2', 'RRAGA', 'RPS6KB1', 'RRAGC', 'RHEB', 'MAPKAP1', 'AKT1S1', 'PRKAG2']",0.9999812599146137,0,0,11
126,T-cell receptor (TCR) signaling pathway WP69,0.2341773126647771,1.2557575225566975,1.8229539415424179,"['MAP2K1', 'JUN', 'CD83', 'CHUK', 'PDPK1', 'ITPR1', 'CBLB', 'GAB2', 'PIK3R1', 'CBL', 'MAPK14', 'MALT1', 'IKBKB', 'MAPK8', 'FYN', 'GRB2', 'RAF1', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.9999812599146137,0,0,21
127,PDGFR-beta pathway WP3972,0.2383221708703966,1.4280167264038233,2.0479642861790186,"['MAPK8', 'MAP2K1', 'JUN', 'MAP3K1', 'RASA1', 'GRB2', 'PIK3R1', 'RAF1', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,10
128,Tumor suppressor activity of SMARCB1 WP4204,0.2383221708703966,1.4280167264038233,2.0479642861790186,"['GLI4', 'SMARCD2', 'SMARCC1', 'SMARCD3', 'CDK6', 'CDKN2A', 'ACTL6A', 'DPF2', 'ARID1B', 'EZH2']",0.9999812599146137,0,0,10
129,MAPK Signaling Pathway WP382,0.2444736987802007,1.1268720539390202,1.5873655549072478,"['LRRK2', 'ARRB1', 'FGF2', 'IKBKB', 'FGF5', 'RPS6KA3', 'PPP3CB', 'RPS6KA5', 'PPP3CC', 'FGF9', 'AKT2', 'PRKACA', 'MAP3K7', 'MAP3K4', 'MAP2K3', 'DAXX', 'MAP2K1', 'DUSP3', 'CHUK', 'PLA2G4B', 'RRAS2', 'TGFBR1', 'MAPK8IP1', 'CDC25B', 'CACNB1', 'CACNB2', 'CACNB4', 'RASA1', 'MAPKAPK2', 'RASA2', 'RAF1', 'PDGFB', 'CACNA1A', 'CACNA1E', 'RAP1B', 'MAPK8', 'FLNB', 'CACNG2', 'PAK2', 'MAP2K5', 'MAP4K4', 'MAPK3', 'MAP3K2', 'NTRK2', 'JUN', 'TGFB2', 'JUND', 'MAP3K1', 'GADD45A', 'NFATC3', 'HSPA2', 'MAPK14', 'NR4A1', 'TAOK1', 'NF1', 'GRB2', 'TAB2', 'MAP3K13', 'LAMTOR3', 'MAP3K14']",0.9999812599146137,0,0,60
130,Aryl Hydrocarbon Receptor Netpath WP2586,0.2471260311341827,1.336723163841808,1.8685475976842505,"['CDKN1A', 'HSP90AA1', 'MAP2K1', 'AIP', 'ARNT', 'AHR', 'PTGS2', 'PSRC1', 'NF1', 'EP300', 'CYP1B1', 'RAF1', 'NFE2L2']",0.9999812599146137,0,0,13
131,TGF-beta Receptor Signaling WP560,0.2471260311341827,1.336723163841808,1.8685475976842505,"['TGIF1', 'SMAD2', 'JUN', 'ZFYVE9', 'SMAD5', 'TGFBR1', 'RUNX2', 'ZEB2', 'SPP1', 'EP300', 'ZNF423', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,13
132,Resistin as a regulator of inflammation WP4481,0.2471878922443302,1.4457807041117978,2.020632559075756,"['IKBKB', 'CHUK', 'AKT2', 'ITPR1', 'MAPK14', 'PLCB1', 'PLCB2', 'PLCD4', 'MAPK3']",0.9999812599146137,0,0,9
133,Genotoxicity pathway WP4286,0.2506784000749001,1.2854065697361337,1.7784685238016626,"['IKBIP', 'CDKN1A', 'PRKAB2', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'TM7SF3', 'FBXO22', 'SMAD5', 'ITPKC', 'LRRFIP2', 'TRIM22', 'PHLDA3']",0.9999812599146137,0,0,16
134,IL-1 signaling pathway WP195,0.2506784000749001,1.2854065697361337,1.7784685238016626,"['MAP2K3', 'MAP3K2', 'MAP3K3', 'MAP2K1', 'JUN', 'MAP3K1', 'CHUK', 'PIK3R1', 'MAPK14', 'IKBKB', 'MAPK8', 'MAPKAPK2', 'TAB2', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.9999812599146137,0,0,16
135,DNA damage response (only ATM dependent) WP710,0.254917449036148,1.1970443349753694,1.6361387697921193,"['CDKN1A', 'PIK3R4', 'PIK3R1', 'FOXO3', 'PIK3C2A', 'PIK3C2B', 'CCND3', 'MAPK8', 'SCP2', 'AKT2', 'DVL1', 'ABL1', 'MAP3K7', 'WNT2', 'LDLR', 'MAP3K4', 'JUN', 'MAP3K1', 'CDKN2A', 'BAD', 'INSR', 'PPP2R5C', 'SOD2', 'CCNG2', 'ATM', 'GRB2', 'PIK3C3']",0.9999812599146137,0,0,27
136,MTHFR deficiency WP4288,0.2565428600364065,1.4686420511245875,1.998028078535011,"['DNMT1', 'GRIN2A', 'PCYT1A', 'SGMS1', 'NDUFAF7', 'MARS', 'DNMT3A', 'EHMT1']",0.9999812599146137,0,0,8
137,Nanoparticle triggered autophagic cell death WP2509,0.2565428600364065,1.4686420511245875,1.998028078535011,"['SH3GLB1', 'VMP1', 'BECN1', 'INSR', 'ATG4A', 'AMBRA1', 'ATG7', 'ATG5']",0.9999812599146137,0,0,8
138,Fas ligand pathway and stress induction of heat shock proteins WP314,0.25680391590056095,1.341113735762565,1.823166954004292,"['DFFB', 'MAPK8', 'DAXX', 'JUN', 'MAP3K1', 'FAF1', 'LMNA', 'MAPKAPK2', 'CFLAR', 'PAK2', 'MAP3K7', 'ACTB']",0.9999812599146137,0,0,12
139,Hepatitis C and Hepatocellular Carcinoma WP3646,0.25680391590056095,1.341113735762565,1.823166954004292,"['CDKN1A', 'UCHL1', 'MAPK8', 'JUN', 'CTTN', 'GRB2', 'PTGS2', 'MAPK14', 'TGFBR1', 'JAK1', 'VAV2', 'MAPK3']",0.9999812599146137,0,0,12
140,IL-6 signaling pathway WP364,0.25680391590056095,1.341113735762565,1.823166954004292,"['MAP2K1', 'RPS6KB1', 'BAD', 'GRB2', 'PIK3R1', 'TYK2', 'MAP3K7', 'JUNB', 'AGT', 'JAK1', 'MAPK3', 'NR2F6']",0.9999812599146137,0,0,12
141,16p11.2 proximal deletion syndrome WP4949,0.25974068438032033,1.2270888992377265,1.654203589516894,"['CCT3', 'UNC13B', 'MAP2K3', 'CCT2', 'PAXIP1', 'HDAC3', 'IGFBP3', 'KMT2C', 'MAZ', 'PPP4R3A', 'PPP2R5D', 'PPP2CA', 'CCT6A', 'PPP4R1', 'PPP2R1A', 'TCP1', 'CCT8', 'EZR', 'CCT5', 'YPEL3', 'MAPK3']",0.9999812599146137,0,0,21
142,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.26033866137147005,1.285329744279946,1.729760718671818,"['NTRK2', 'PRKAB2', 'PRKAA1', 'HOMER1', 'PRKAG2', 'PIK3R1', 'GRM1', 'RPTOR', 'GRIN2A', 'RPS6KB1', 'DLG4', 'RHEB', 'AKT2', 'NF1', 'MAPK3']",0.9999812599146137,0,0,15
143,Gastric Cancer Network 1 WP2361,0.26640881480114065,1.4991494314620826,1.9829598116229192,"['CCNA1', 'INO80D', 'RNF216', 'CASTOR3', 'ACTL6A', 'CEP192', 'GATD3B']",0.9999812599146137,0,0,7
144,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.26640881480114065,1.4991494314620826,1.9829598116229192,"['DNMT1', 'DNMT3A', 'EP300', 'ATM', 'FOXO3', 'TERF2', 'ETV6']",0.9999812599146137,0,0,7
145,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.267149761423933,1.3463552670328685,1.7771160791470846,"['IKBKB', 'MAPK8', 'JUN', 'CHUK', 'AKT2', 'TNFSF12', 'MAPK14', 'RAF1', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.9999812599146137,0,0,11
146,Gastrin signaling pathway WP4659,0.2687935798061771,1.1802747296543294,1.5506585782107014,"['ITGB1', 'CDKN1A', 'ROCK1', 'ARHGEF28', 'ARRB1', 'PIK3R1', 'FOXO3', 'PTGS2', 'HDAC7', 'IKBKB', 'MAPK8', 'FYN', 'PRKACA', 'MAPK3', 'CHGA', 'MAP2K1', 'JUN', 'CHUK', 'CDKN2A', 'BAD', 'RPS6', 'MAPK14', 'RPS6KB1', 'TCF4', 'GRB2', 'PRKD1', 'RAF1', 'LAMTOR3']",0.9999812599146137,0,0,28
147,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2692563745778942,1.2242330894622,1.6063055710586363,"['HSPA9', 'PSMD14', 'TUBB', 'CASK', 'UBE2L6', 'UBE2G1', 'HSPA2', 'TUBB4B', 'TUBB4A', 'TUBA1B', 'PSMC5', 'PSMC6', 'PSMC3', 'TUBB3', 'PSMC4', 'PSMD2', 'RNF19A', 'PSMD3', 'PSMD1', 'STUB1']",0.9999812599146137,0,0,20
148,Nicotine Activity on Dopaminergic Neurons WP1602,0.2875789713979285,1.606040268456376,2.0015401688608265,"['CHRNB2', 'CDK5', 'PRKACA', 'KCNK3', 'PPP1CA']",0.9999812599146137,0,0,5
149,TP53 network WP1742,0.2875789713979285,1.606040268456376,2.0015401688608265,"['CDKN1A', 'CDKN2A', 'GADD45A', 'ABL1', 'ATM']",0.9999812599146137,0,0,5
150,Development of ureteric collection system WP5053,0.29026703106210877,1.36059250359644,1.6829903164397566,"['ITGB1', 'TGFB2', 'ANOS1', 'ILK', 'SPRY1', 'FAT4', 'ETV4', 'FREM1', 'ROBO1']",0.9999812599146137,0,0,9
151,Ebola Virus Pathway on Host WP4217,0.29171494952230675,1.1611160488663494,1.430469606199414,"['ITGB1', 'TSG101', 'CLTC', 'VPS4A', 'IQGAP1', 'PIK3R1', 'ACTB', 'TBK1', 'C1QBP', 'VPS11', 'EP300', 'FLNB', 'HAVCR2', 'MAPK3', 'VPS18', 'GSN', 'DDX58', 'DAB2IP', 'MERTK', 'TPCN2', 'VAV2', 'TIAM1', 'RASA2', 'VPS41', 'TYRO3', 'RAB9A', 'TOP1', 'HLA-DRB1']",0.9999812599146137,0,0,28
152,B Cell Receptor Signaling Pathway WP23,0.29221706205780257,1.1825735095764769,1.4548709815458787,"['KLF11', 'MAP2K1', 'JUN', 'CHUK', 'CD81', 'PDPK1', 'NFATC3', 'PIK3R1', 'GAB2', 'CBL', 'MAPK14', 'MALT1', 'VAV2', 'IKBKB', 'MAPK8', 'TEC', 'RAPGEF1', 'GRB2', 'FYN', 'RAF1', 'MAP3K7', 'MAPK4', 'NCK1']",0.9999812599146137,0,0,23
153,Alanine and aspartate metabolism WP106,0.2985114041603966,1.7130076936840222,2.0709357554807286,"['DARS', 'PC', 'GOT2', 'GPT']",0.9999812599146137,0,0,4
154,Osteoclast Signaling WP12,0.2985114041603966,1.7130076936840222,2.0709357554807286,"['AIMP2', 'MAPK8', 'PDGFB', 'SPP1']",0.9999812599146137,0,0,4
155,16p11.2 distal deletion syndrome WP4950,0.3033302380550027,1.3705892889127709,1.635021428487972,"['RAB4A', 'RABEP2', 'CD81', 'INSR', 'GRB2', 'TUFM', 'VAV2', 'SDCCAG8']",0.9999812599146137,0,0,8
156,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3033302380550027,1.3705892889127709,1.635021428487972,"['RAB4A', 'MPZ', 'NEFL', 'MFN2', 'KIF1B', 'RABAC1', 'RAB11A', 'DNM2']",0.9999812599146137,0,0,8
157,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.3061400281739091,1.2850228556063459,1.5210978396473638,"['GABRB3', 'NTRK2', 'GABRA1', 'SLC12A5', 'ROCK1', 'CREM', 'AP2A1', 'PIK3R1', 'AP2B1', 'GABRD', 'GABRG3']",0.9999812599146137,0,0,11
158,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.3085782543777103,1.9270190501744031,2.265750086774883,"['DDX1', 'DROSHA', 'ATM']",0.9999812599146137,0,0,3
159,HIF1A and PPARG regulation of glycolysis WP2456,0.3085782543777103,1.9270190501744031,2.265750086774883,"['LDHA', 'SLC2A1', 'GAPDH']",0.9999812599146137,0,0,3
160,NAD Biosynthesis II (from tryptophan) WP2485,0.3085782543777103,1.9270190501744031,2.265750086774883,"['TDO2', 'NMNAT1', 'NADSYN1']",0.9999812599146137,0,0,3
161,Osteoblast Signaling WP322,0.3085782543777103,1.9270190501744031,2.265750086774883,"['PDGFRA', 'BGLAP', 'PDGFB']",0.9999812599146137,0,0,3
162,Pentose Phosphate Metabolism WP134,0.3085782543777103,1.9270190501744031,2.265750086774883,"['RPE', 'PGLS', 'TKT']",0.9999812599146137,0,0,3
163,Type III interferon signaling WP2113,0.3085782543777103,1.9270190501744031,2.265750086774883,"['IFNLR1', 'TYK2', 'JAK1']",0.9999812599146137,0,0,3
164,Translation Factors WP107,0.31319170722955475,1.2095410054167062,1.4042042841773756,"['EIF5A', 'EIF4A1', 'EIF2B3', 'EIF2B2', 'EIF1AY', 'EEF2', 'GSPT2', 'EEF1G', 'EEF2K', 'EIF2S3', 'EIF3I', 'EIF3G', 'EIF2B1', 'EIF3C', 'EIF3A', 'EIF4G1']",0.9999812599146137,0,0,16
165,Benzene metabolism WP3891,0.3136315255898588,2.569206008583691,2.97908805954896,"['EPHX1', 'DHDH']",0.9999812599146137,0,0,2
166,Cells and molecules involved in local acute inflammatory response  WP4493,0.3136315255898588,2.569206008583691,2.97908805954896,"['ITGB1', 'C5']",0.9999812599146137,0,0,2
167,Irinotecan pathway WP229,0.3136315255898588,2.569206008583691,2.97908805954896,"['ABCC1', 'CYP3A5']",0.9999812599146137,0,0,2
168,miR-517 relationship with ARCN1 and USP1 WP3596,0.3136315255898588,2.569206008583691,2.97908805954896,"['CDKN1A', 'ARCN1']",0.9999812599146137,0,0,2
169,Nucleotide GPCRs WP80,0.3136315255898588,2.569206008583691,2.97908805954896,"['ADORA2A', 'LTB4R']",0.9999812599146137,0,0,2
170,Role of Osx and miRNAs in tooth development WP3971,0.3136315255898588,2.569206008583691,2.97908805954896,"['NOTCH2', 'RUNX2']",0.9999812599146137,0,0,2
171,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.3136315255898588,2.569206008583691,2.97908805954896,"['ATP4A', 'CHRM1']",0.9999812599146137,0,0,2
172,Genes controlling nephrogenesis WP4823,0.3176774608176553,1.3836856133391187,1.5866981470984192,"['NOTCH2', 'ITGB1', 'PDGFB', 'ILK', 'ETV4', 'NCK1', 'CD2AP']",0.9999812599146137,0,0,7
173,MECP2 and Associated Rett Syndrome WP3584,0.33776311032503703,1.1627080365964764,1.2620154953581928,"['GRIA1', 'RBFOX1', 'ARHGEF26', 'CNP', 'FOXG1', 'RPS6', 'TET2', 'TET1', 'FGF2', 'FGF5', 'FUT8', 'GPRIN1', 'TET3', 'SP3', 'NF1', 'SGK1', 'TARDBP', 'GRIA3', 'EZH2']",0.9999812599146137,0,0,19
174,RANKL/RANK signaling pathway WP2018,0.33966185896793366,1.199318263365626,1.2950294840194103,"['MAP2K1', 'JUN', 'CHUK', 'GAB2', 'PIK3R1', 'CBL', 'MAPK14', 'PAPSS2', 'IKBKB', 'MAPK8', 'AKT2', 'TAB2', 'MAP3K7', 'MAPK3']",0.9999812599146137,0,0,14
175,Metapathway biotransformation Phase I and II WP702,0.35063088084523636,1.1193452562438477,1.1730975926705969,"['GSTP1', 'MGST2', 'HS6ST1', 'CYP2C18', 'NAT14', 'CYP3A5', 'HS6ST2', 'HS6ST3', 'HS2ST1', 'CHST11', 'CYP4V2', 'NDST3', 'CYP1B1', 'GAL3ST3', 'GSTM4', 'GSTM3', 'GLYATL2', 'NAA30', 'GPX3', 'EPHX1', 'KCNAB1', 'KCNAB2', 'CYP7B1', 'CYP27A1', 'CYP2U1', 'CHST1', 'NAT8L']",0.9999812599146137,0,0,27
176,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.3516732567202922,1.427442207307979,1.4917524505004844,"['MAP3K1', 'ROCK1', 'FGF9', 'SOX9', 'MAP3K4']",0.9999812599146137,0,0,5
177,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.3516732567202922,1.427442207307979,1.4917524505004844,"['IKBKB', 'EGLN2', 'CHUK', 'CFLAR', 'PTGS2']",0.9999812599146137,0,0,5
178,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3516732567202922,1.427442207307979,1.4917524505004844,"['IKBKB', 'TBK1', 'CHUK', 'ITPR1', 'NFKBIE']",0.9999812599146137,0,0,5
179,Cell migration and invasion through p75NTR WP4561,0.3517468770453544,1.2847931219774316,1.3424076927021857,"['EFNB2', 'NTRK2', 'TIAM1', 'JUN', 'EFNA3', 'ADAMTS13', 'KIDINS220', 'AKT2']",0.9999812599146137,0,0,8
180,ATM Signaling Network in Development and Disease  WP3878,0.3543679469032576,1.193128098697106,1.2377743646739812,"['HDAC4', 'PRKAA1', 'ATMIN', 'H2AFX', 'RNF40', 'PTPA', 'RNF168', 'CDK5', 'ATM', 'CEP63', 'LBR', 'CDK5R1', 'ATR']",0.9999812599146137,0,0,13
181,Hippo-Merlin Signaling Dysregulation WP4541,0.3602637485590879,1.1215228376588333,1.1449838403169772,"['ITGB1', 'PDGFRA', 'NTRK2', 'INSR', 'CDH8', 'PPP1CA', 'CDH6', 'DCAF1', 'LATS1', 'DDB1', 'CUL4A', 'PPP1CC', 'CDH4', 'LIN28B', 'CDH2', 'CDH20', 'PRKAR2A', 'CDH12', 'ITGB8', 'ITGA7', 'PRKACA', 'PAK3', 'PAK2', 'VGLL4']",0.9999812599146137,0,0,24
182,IL-5 signaling pathway WP127,0.36282925270108934,1.2236303123399899,1.2405444729152315,"['MAP2K1', 'JUN', 'RPS6KB1', 'RPS6', 'GRB2', 'PIK3R1', 'FOXO3', 'RAF1', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,10
183,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.3726014685656952,1.468138946399816,1.4494141252525685,"['CDKN1A', 'SPP1', 'ENPP1', 'ROS1']",0.9999812599146137,0,0,4
184,miRNAs involvement in the immune response in sepsis WP4329,0.3916046402069337,1.284640171858217,1.2043533971799107,"['IKBKB', 'MAPK8', 'CHUK', 'TAB2', 'MAPK14', 'MAP3K7']",0.9999812599146137,0,0,6
185,NAD+ biosynthetic pathways WP3645,0.3916046402069337,1.284640171858217,1.2043533971799107,"['NMNAT1', 'TDO2', 'TNKS2', 'SIRT7', 'NADSYN1', 'SIRT2']",0.9999812599146137,0,0,6
186,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3919080776353261,1.1518651489428813,1.078984294065184,"['SMAD2', 'CEBPA', 'CDKN1A', 'TGFB2', 'ICMT', 'MAOB', 'DICER1', 'ACTB', 'RUNX2', 'TARBP2', 'LMNA', 'SPP1', 'JUNB']",0.9999812599146137,0,0,13
187,G1 to S cell cycle control WP45,0.39498835249374326,1.13363945847518,1.0530365614618828,"['PRIM2', 'CDKN1A', 'CDKN2A', 'GADD45A', 'RPA2', 'CCNA1', 'CREB3', 'CCND3', 'CCNB1', 'POLA2', 'CDK6', 'CCNG2', 'MCM3', 'ATM', 'MNAT1']",0.9999812599146137,0,0,15
188,15q13.3 copy number variation syndrome WP4942,0.3978798835832843,1.5414542527502013,1.4206121304866923,"['OTUD7A', 'FYN', 'FAN1']",0.9999812599146137,0,0,3
189,Canonical NF-KB pathway WP4562,0.3978798835832843,1.5414542527502013,1.4206121304866923,"['IKBKB', 'CHUK', 'NFKBIE']",0.9999812599146137,0,0,3
190,Leptin and adiponectin WP3934,0.3978798835832843,1.5414542527502013,1.4206121304866923,"['PRKAA1', 'CPT1A', 'ADIPOR2']",0.9999812599146137,0,0,3
191,Tryptophan metabolism WP465,0.400951090978433,1.2090906217403672,1.1050070551823767,"['ALDH3A2', 'MAOB', 'TDO2', 'OGDH', 'CYP1B1', 'DHCR24', 'CYP7B1', 'CYP2C18']",0.9999812599146137,0,0,8
192,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.40631991815794893,1.1678885630498534,1.051817320441001,"['ITGB1', 'RPTOR', 'SMAD2', 'DEPTOR', 'EIF2B2', 'RPS6KB1', 'MAPKAP1', 'JKAMP', 'AKT1S1', 'ILK']",0.9999812599146137,0,0,10
193,Signaling of Hepatocyte Growth Factor Receptor WP313,0.40631991815794893,1.1678885630498534,1.051817320441001,"['ITGB1', 'RAP1B', 'MAPK8', 'MAP2K1', 'JUN', 'RASA1', 'RAPGEF1', 'GRB2', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,10
194,Regulation of Microtubule Cytoskeleton WP2038,0.4096364756756896,1.141952065028988,1.0191752683626194,"['TIAM1', 'ROCK1', 'CFL2', 'MAP1B', 'TAOK1', 'DVL1', 'LIMK1', 'MAPKAPK2', 'ABL1', 'TPPP', 'PRKACA', 'CLASP1']",0.9999812599146137,0,0,12
195,Melanoma WP4685,0.4139240457100625,1.1012161330049262,0.9713527829309859,"['CDKN1A', 'MAP2K1', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3R1', 'GRM3', 'GRIN2A', 'CDK6', 'AKT2', 'NF1', 'GRB2', 'POLK', 'RAF1', 'CALM1', 'LAMTOR3', 'VCL', 'MAPK3']",0.9999812599146137,0,0,18
196,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.41626599149103644,1.2845637583892617,1.1258312686583984,"['MAP2K3', 'PRKAA1', 'MAP2K1', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,5
197,ERK Pathway in Huntington's Disease WP3853,0.41626599149103644,1.2845637583892617,1.1258312686583984,"['NTRK2', 'RPS6KA5', 'HTT', 'RAF1', 'GRM1']",0.9999812599146137,0,0,5
198,Kynurenine Pathway and links to Cellular Senescence WP5044,0.41626599149103644,1.2845637583892617,1.1258312686583984,"['CDKN1A', 'KLF5', 'TDO2', 'AHR', 'EIF2AK4']",0.9999812599146137,0,0,5
199,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.41626599149103644,1.2845637583892617,1.1258312686583984,"['JUN', 'ITPR1', 'LPP', 'VCL', 'MAPK3']",0.9999812599146137,0,0,5
200,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.41626599149103644,1.2845637583892617,1.1258312686583984,"['PRKAA1', 'SCD', 'PPARA', 'MED15', 'LDLR']",0.9999812599146137,0,0,5
201,Estrogen signaling pathway WP712,0.4235347949184195,1.1989435043423762,1.0300358733340054,"['IKBKB', 'MAP2K1', 'JUN', 'CHUK', 'GPER1', 'MAPK14', 'PRKACA']",0.9999812599146137,0,0,7
202,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4288737856681112,1.1304651788115085,0.9570434653883959,"['TBK1', 'AP1G1', 'DDX58', 'DHX58', 'BSG', 'EP300', 'NUP98', 'TANK', 'IFIT2', 'JAK1', 'HAVCR2']",0.9999812599146137,0,0,11
203,Modulators of TCR signaling and T cell activation WP5072,0.4297407665187494,1.113353062505605,0.9403080703899338,"['CHUK', 'PDPK1', 'CBLB', 'RNF7', 'PIK3R1', 'MALT1', 'IKBKB', 'TMEM222', 'RASA2', 'PCBP2', 'ARIH2', 'GRB2', 'MAP3K14']",0.9999812599146137,0,0,13
204,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['GSTP1', 'COX5A']",0.9999812599146137,0,0,2
205,Complement Activation WP545,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['C5', 'C1S']",0.9999812599146137,0,0,2
206,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['PPARA', 'CYP2C18']",0.9999812599146137,0,0,2
207,Metastatic brain tumor WP2249,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['CDK6', 'PIK3R1']",0.9999812599146137,0,0,2
208,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['PRKAA1', 'SIX4']",0.9999812599146137,0,0,2
209,Mitochondrial fatty acid synthesis pathway WP4317,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['HSD17B12', 'MCAT']",0.9999812599146137,0,0,2
210,Somatic sex determination WP4814,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['FGF9', 'SOX9']",0.9999812599146137,0,0,2
211,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.4307855851619398,1.7126251788268956,1.4422783799408085,"['JAK1', 'MAPK3']",0.9999812599146137,0,0,2
212,Airway smooth muscle cell contraction WP4962,0.44593316808913575,1.2844873859366612,1.0373342683623887,"['ROCK1', 'GDI1', 'PLCB1', 'CALM1']",0.9999812599146137,0,0,4
213,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.44593316808913575,1.2844873859366612,1.0373342683623887,"['TRPC1', 'ITPR1', 'CCK', 'PLCB1']",0.9999812599146137,0,0,4
214,Ganglio Sphingolipid Metabolism WP1423,0.44593316808913575,1.2844873859366612,1.0373342683623887,"['ST8SIA3', 'B3GALT1', 'B3GALT4', 'ST8SIA5']",0.9999812599146137,0,0,4
215,Acute viral myocarditis WP4298,0.4470091900449084,1.0817674234050392,0.871013302339802,"['DFFB', 'ENDOG', 'CXADR', 'ILK', 'PIK3R1', 'ACTB', 'SGCD', 'RASA1', 'JKAMP', 'ABL1', 'CASP2', 'DMD', 'FYN', 'JAK1', 'MAPK3', 'EIF4G1']",0.9999812599146137,0,0,16
216,Prader-Willi and Angelman Syndrome WP3998,0.4491309772821491,1.1010527933604857,0.881327496081332,"['GABRB3', 'PCSK1', 'PCM1', 'HERC2', 'CDK6', 'CDKN2A', 'NIPA1', 'GNRH1', 'MDM4', 'GHRL', 'GABRG3', 'GABRD']",0.9999812599146137,0,0,12
217,Angiogenesis WP1539,0.44938730673980243,1.1856977608857309,0.9484042630879285,"['PDGFRA', 'PDGFB', 'TIMP2', 'ARNT', 'MAPK14', 'FGF2']",0.9999812599146137,0,0,6
218,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.44938730673980243,1.1856977608857309,0.9484042630879285,"['PRKAA1', 'LDHA', 'RPS6', 'SLC2A1', 'KEAP1', 'NFE2L2']",0.9999812599146137,0,0,6
219,IL-7 signaling pathway WP205,0.44938730673980243,1.1856977608857309,0.9484042630879285,"['MAP2K1', 'BAD', 'FYN', 'PIK3R1', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,6
220,Monoamine GPCRs WP58,0.44938730673980243,1.1856977608857309,0.9484042630879285,"['CHRM3', 'CHRM1', 'HTR1F', 'CHRM5', 'ADRB1', 'ADRA2C']",0.9999812599146137,0,0,6
221,Trans-sulfuration and one-carbon metabolism WP2525,0.44938730673980243,1.1856977608857309,0.9484042630879285,"['AHCYL2', 'DNMT1', 'AHCY', 'AHCYL1', 'DNMT3A', 'PSPH']",0.9999812599146137,0,0,6
222,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.44987637682560755,1.1169939223936418,0.892235144338355,"['ITGB1', 'LATS1', 'MAPK8', 'SGMS1', 'ITGB8', 'LIMD1', 'PAK3', 'PAK2', 'ACTB', 'MAP4K4']",0.9999812599146137,0,0,10
223,p38 MAPK Signaling Pathway WP400,0.44987637682560755,1.1169939223936418,0.892235144338355,"['TGFB2', 'DAXX', 'RPS6KA5', 'MAP3K1', 'MAPKAPK2', 'GRB2', 'MAP3K9', 'MAPK14', 'MAP3K7', 'TGFBR1']",0.9999812599146137,0,0,10
224,Parkinson's disease pathway WP2371,0.44987637682560755,1.1169939223936418,0.892235144338355,"['UCHL1', 'PINK1', 'UBB', 'LRRK2', 'HTRA2', 'CASP2', 'UBE2L6', 'UBE2G1', 'EPRS', 'MAPK14']",0.9999812599146137,0,0,10
225,Type 2 papillary renal cell carcinoma WP4241,0.44987637682560755,1.1169939223936418,0.892235144338355,"['CDKN1A', 'SETD2', 'TGFB2', 'EGLN3', 'EGLN2', 'CADM2', 'PDGFB', 'SLC2A1', 'EP300', 'ARNT']",0.9999812599146137,0,0,10
226,Folate Metabolism WP176,0.45014398852899573,1.1417995104185326,0.9113704083076529,"['SLC46A1', 'AHCY', 'GPX3', 'RFK', 'INSR', 'HBA1', 'SOD2', 'LDLR']",0.9999812599146137,0,0,8
227,Nuclear receptors WP170,0.45014398852899573,1.1417995104185326,0.9113704083076529,"['NR4A1', 'THRB', 'NR2F1', 'RORA', 'ROR1', 'NR2C2', 'PPARA', 'NR2F6']",0.9999812599146137,0,0,8
228,Oxidation by Cytochrome P450 WP43,0.45014398852899573,1.1417995104185326,0.9113704083076529,"['CYP27A1', 'CYB5B', 'CYP2U1', 'CYP4V2', 'CYP1B1', 'CYP7B1', 'CYP3A5', 'CYP2C18']",0.9999812599146137,0,0,8
229,The influence of laminopathies on Wnt signaling WP4844,0.45014398852899573,1.1417995104185326,0.9113704083076529,"['CEBPA', 'ICMT', 'CDK6', 'LMNA', 'SPP1', 'DICER1', 'TARBP2', 'RUNX2']",0.9999812599146137,0,0,8
230,Wnt signaling WP428,0.47200312426367835,1.0466458907667107,0.7857899944302084,"['JUN', 'CAMK2D', 'CTBP2', 'RYK', 'SERPINF1', 'CHD8', 'CSNK2A2', 'NFATC3', 'PRICKLE1', 'SENP2', 'LRP6', 'CCND3', 'PPP3CB', 'MAPK8', 'PPP3CC', 'DVL1', 'ROR1', 'PLCB1', 'MAP3K7', 'WNT2', 'PLCB2', 'CAMK2G']",0.9999812599146137,0,0,22
231,BDNF-TrkB Signaling WP3676,0.47297379202638534,1.1009713210734442,0.8243140729525624,"['NTRK2', 'MAP2K1', 'EEF2K', 'HOMER1', 'RPS6KB1', 'RHEB', 'DLG4', 'GRB2', 'GAB2']",0.9999812599146137,0,0,9
232,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.47297379202638534,1.1009713210734442,0.8243140729525624,"['MAP2K1', 'STAR', 'AKT2', 'FSHR', 'ARRB1', 'RAF1', 'PLCB1', 'PLCB2', 'MAPK3']",0.9999812599146137,0,0,9
233,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.47612426666018653,1.1238920225624496,0.8340137398092424,"['YAP1', 'VMP1', 'LATS1', 'RASSF5', 'STK38L', 'FOXO3', 'MAPK14']",0.9999812599146137,0,0,7
234,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.4796684118832593,1.1676632092739476,0.8578357129842271,"['CNP', 'PDGFB', 'OMG', 'SOX9', 'FGF2']",0.9999812599146137,0,0,5
235,One-carbon metabolism WP241,0.4796684118832593,1.1676632092739476,0.8578357129842271,"['AHCYL2', 'DNMT1', 'ALDH1L1', 'AHCY', 'DNMT3A']",0.9999812599146137,0,0,5
236,DNA damage response WP707,0.48081002870744,1.053919335017881,0.7717672520345141,"['CDKN1A', 'GADD45A', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CCND3', 'CCNB1', 'CDK6', 'CDK5', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A', 'ATR']",0.9999812599146137,0,0,16
237,MET in type 1 papillary renal cell carcinoma WP4205,0.48081002870744,1.053919335017881,0.7717672520345141,"['CDKN1A', 'MAP2K1', 'JUN', 'BAD', 'PIK3R1', 'CBL', 'RAP1B', 'MAPK8', 'AKT2', 'RAPGEF1', 'GRB2', 'STRN', 'RAF1', 'PAK3', 'PAK2', 'MAPK3']",0.9999812599146137,0,0,16
238,Aflatoxin B1 metabolism WP699,0.48196090272712855,2.5687851971037814,1.8749364917822895,['EPHX1'],0.9999812599146137,0,0,1
239,COVID-19 adverse outcome pathway WP4891,0.48196090272712855,2.5687851971037814,1.8749364917822895,['AGT'],0.9999812599146137,0,0,1
240,Gastric acid production WP2596,0.48196090272712855,2.5687851971037814,1.8749364917822895,['CCK'],0.9999812599146137,0,0,1
241,MED and Pseudoachondroplasia genes WP4789,0.48196090272712855,2.5687851971037814,1.8749364917822895,['COL9A3'],0.9999812599146137,0,0,1
242,15q11.2 copy number variation syndrome WP4940,0.4835876051409931,1.2844110544674001,0.9331539040378674,"['NIPA1', 'TUBGCP3', 'TUBGCP4']",0.9999812599146137,0,0,3
243,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.4835876051409931,1.2844110544674001,0.9331539040378674,"['SMURF1', 'RUNX2', 'BMPR1A']",0.9999812599146137,0,0,3
244,Cancer immunotherapy by CTLA4 blockade WP4582,0.4835876051409931,1.2844110544674001,0.9331539040378674,"['PPP2CA', 'PIK3R1', 'HLA-DRB1']",0.9999812599146137,0,0,3
245,Genes targeted by miRNAs in adipocytes WP1992,0.4835876051409931,1.2844110544674001,0.9331539040378674,"['HDAC4', 'HCN4', 'GJA1']",0.9999812599146137,0,0,3
246,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.48834325035369314,1.0629741611173973,0.761872633363683,"['MAP2K3', 'PDGFRA', 'CDKN1A', 'HSP90AA1', 'MAPK8', 'JUN', 'CDKN2A', 'CFLAR', 'MAPK14', 'JUNB', 'HBEGF', 'NFE2L2']",0.9999812599146137,0,0,12
247,Apoptosis Modulation and Signaling WP1772,0.49152950416142716,1.0384710206000562,0.7375567127754705,"['HRK', 'DFFB', 'DAXX', 'JUN', 'ENDOG', 'CDKN2A', 'BAD', 'HTRA2', 'CFLAR', 'IKBKB', 'PIDD1', 'MAPK8', 'CAPNS1', 'BAG3', 'PEA15', 'CASP2', 'PRKD1', 'MAP3K14', 'MAPK3']",0.9999812599146137,0,0,19
248,Leptin signaling pathway WP2034,0.49152950416142716,1.0384710206000562,0.7375567127754705,"['PTPN1', 'MAP2K1', 'PRKAA1', 'CHUK', 'ROCK1', 'BAD', 'RPS6', 'PIK3R1', 'MAPK14', 'IKBKB', 'MAPK8', 'RPS6KB1', 'CFL2', 'FYN', 'GRB2', 'RAF1', 'SOCS7', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,19
249,Nephrotic syndrome WP4758,0.4929862639604294,1.0703405017921146,0.7570239732536544,"['SMARCAL1', 'ANLN', 'PTPRO', 'LMNA', 'PMM2', 'MYH9', 'GPC5', 'ALG1', 'SYNPO', 'CD2AP']",0.9999812599146137,0,0,10
250,Phosphoinositides metabolism WP4971,0.4929862639604294,1.0703405017921146,0.7570239732536544,"['PIP4P1', 'PIK3R4', 'PIP4K2A', 'PIK3C3', 'PIP4K2C', 'PIK3C2A', 'PLCB1', 'PLCB2', 'PLCD4', 'PIK3C2B']",0.9999812599146137,0,0,10
251,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.49545912781199286,1.039757351903864,0.7301908274067228,"['APC2', 'JUN', 'CTBP2', 'RYK', 'CHD8', 'SERPINF1', 'CSNK2A2', 'SENP2', 'LRP6', 'CCND3', 'CDK6', 'H2AFY2', 'DVL1', 'ROR1', 'MAP3K7', 'WNT2', 'EZH2']",0.9999812599146137,0,0,17
252,GABA receptor Signaling WP4159,0.4985993697983126,1.0815916739726803,0.7527362908592395,"['GABRB3', 'GABBR2', 'GABRA1', 'AP2A1', 'AP2B1', 'GABRD', 'GABRG3', 'GPHN']",0.9999812599146137,0,0,8
253,Amino Acid metabolism WP3925,0.5046444794699059,1.0274932614555257,0.7027037703973479,"['PDHX', 'OAT', 'HIBADH', 'MDH1', 'MCCC1', 'GOT2', 'EPRS', 'GLS', 'ACLY', 'LARS2', 'LDHA', 'PKM', 'PC', 'TDO2', 'AUH', 'P4HA2', 'OGDH', 'BCAT1', 'GLUL', 'DLD']",0.9999812599146137,0,0,20
254,1q21.1 copy number variation syndrome WP4905,0.5058343565347495,1.1008899800521712,0.7503071864708398,"['PRKAA1', 'GJA1', 'PRKAB2', 'ACP6', 'PRKAG2', 'TJP2']",0.9999812599146137,0,0,6
255,BMP Signaling Pathway in Eyelid Development WP3927,0.5163127738691904,1.1416472833542077,0.7546774270810888,"['JUN', 'MAP3K1', 'SMAD5', 'MAPK3']",0.9999812599146137,0,0,4
256,Transcription co-factors SKI and SKIL protein partners WP4533,0.5163127738691904,1.1416472833542077,0.7546774270810888,"['LATS1', 'HDAC3', 'NF1', 'MERTK']",0.9999812599146137,0,0,4
257,Tryptophan catabolism leading to NAD+ production WP4210,0.5163127738691904,1.1416472833542077,0.7546774270810888,"['NMNAT1', 'TDO2', 'NMNAT3', 'NADSYN1']",0.9999812599146137,0,0,4
258,Oxidative Damage WP3941,0.5180329008867575,1.050817228995138,0.6911398547035703,"['CDKN1A', 'C5', 'MAP3K1', 'C1S', 'BAD', 'GADD45A', 'TNK2', 'MAP3K9', 'NFKBIE']",0.9999812599146137,0,0,9
259,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5200889252750233,1.027448869752422,0.6717003206806049,"['YAP1', 'UPF1', 'CDKN2A', 'H2AFX', 'ACTL6A', 'TERF2', 'LATS1', 'RAD52', 'CDK5', 'ABL1', 'NABP2', 'ATM', 'RAD9A', 'ATR']",0.9999812599146137,0,0,14
260,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5220650340117621,1.0167295428006826,0.6608366983419022,"['MAP2K1', 'THRB', 'BAD', 'RPS6', 'DIO2', 'FRS2', 'SLC16A10', 'MAPK14', 'RPTOR', 'CREB3', 'RPS6KA6', 'RPS6KB1', 'RHEB', 'AKT1S1', 'PRKG2', 'GRB2', 'PRKACA', 'RAF1', 'PLCB1']",0.9999812599146137,0,0,19
261,Ciliary landscape WP4352,0.5227355794333097,1.001871954455541,0.6498938255563974,"['DOCK5', 'TTC26', 'GDI1', 'ZMYND19', 'IFT172', 'IFT52', 'APMAP', 'NEFL', 'NEFM', 'NINL', 'BBS5', 'CEP290', 'IQCB1', 'ZYG11B', 'CNOT6L', 'EXOC8', 'NUP133', 'IFT80', 'ARMC8', 'ARFGAP3', 'DYNLL2', 'MYL6', 'RABEP2', 'EXOC4', 'MCM3', 'CD2BP2', 'EXOC3', 'ANKS6', 'EXOC2', 'ARL8B', 'YAP1', 'POM121', 'DDX5', 'WDR26', 'CTBP2', 'SSNA1', 'VPS4A', 'HTRA2', 'IQGAP1', 'EHBP1', 'BBS2', 'RNGTT', 'RHBDD2', 'RANBP9', 'COPS3', 'EHD3', 'PSMC6', 'MFAP1', 'WDR60', 'PSMC4', 'VAPB', 'GID8', 'DYNLRB1', 'CALM1', 'YPEL5']",0.9999812599146137,0,0,55
262,Energy Metabolism WP1541,0.5269173020550951,1.0274341043571813,0.6582890155273126,"['PRKAA1', 'PPP3CB', 'PRKAB2', 'PPP3CC', 'PRKAG2', 'EP300', 'NRF1', 'TFB1M', 'FOXO3', 'MAPK14', 'PPARA', 'CAMK2G']",0.9999812599146137,0,0,12
263,Eukaryotic Transcription Initiation WP405,0.5269173020550951,1.0274341043571813,0.6582890155273126,"['POLR2A', 'POLR3B', 'TAF13', 'POLR2C', 'TAF9', 'ILK', 'POLR2G', 'GTF2H1', 'POLR3H', 'TAF6', 'MNAT1', 'POLR2J']",0.9999812599146137,0,0,12
264,Neovascularisation processes WP4331,0.5273384602135051,1.0576701268742792,0.6768165435238547,"['SMAD2', 'MAPK8', 'TGFB2', 'PDGFB', 'SMAD5', 'TGFBR1', 'MAPK3']",0.9999812599146137,0,0,7
265,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5341160187841039,1.0138839696819437,0.6358494232704096,"['PTPRT', 'PDGFRA', 'MAPKAP1', 'SETD7', 'IFNLR1', 'TYK2', 'MAPK14', 'RPTOR', 'PTPRD', 'MAPK8', 'DEPTOR', 'AKT1S1', 'MAPK4', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,15
266,Benzo(a)pyrene metabolism WP696,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['EPHX1', 'CYP1B1']",0.9999812599146137,0,0,2
267,exRNA mechanism of action and biogenesis WP2805,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['DROSHA', 'DICER1']",0.9999812599146137,0,0,2
268,LDLRAD4 and what we know about it WP4904,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['SMAD2', 'TGFBR1']",0.9999812599146137,0,0,2
269,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['AHCY', 'ADK']",0.9999812599146137,0,0,2
270,Nephrogenesis WP5052,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['NOTCH2', 'MEIS1']",0.9999812599146137,0,0,2
271,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['IKBKB', 'CHUK']",0.9999812599146137,0,0,2
272,Tamoxifen metabolism WP691,0.5361956147926886,1.2843347639484979,0.8004696449874346,"['CYP1B1', 'CYP3A5']",0.9999812599146137,0,0,2
273,ErbB signaling pathway WP673,0.5400015618487329,1.001234494520216,0.6169439219575443,"['CDKN1A', 'MAP2K1', 'CAMK2D', 'JUN', 'SHC3', 'PDPK1', 'BAD', 'CBLB', 'NRG2', 'PIK3R1', 'CBL', 'MAPK8', 'RPS6KB1', 'AKT2', 'ABL1', 'GRB2', 'RAF1', 'PAK3', 'PAK2', 'CAMK2G', 'NCK1', 'HBEGF', 'MAPK3']",0.9999812599146137,0,0,23
274,Genes related to primary cilium development (based on CRISPR) WP4536,0.5402222176333894,0.9987994477459632,0.6150354402206375,"['CEP104', 'TTC26', 'C2CD3', 'IFT172', 'CEP120', 'TULP3', 'KATNB1', 'IFT52', 'ARL13B', 'TMEM67', 'KIAA0753', 'TRAPPC11', 'CEP192', 'PIBF1', 'BBS5', 'DYNC2H1', 'BBS2', 'CEP295', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'ICK', 'WDR60', 'SASS6', 'FGFR1OP', 'CEP162', 'WDPCP', 'CEP44']",0.9999812599146137,0,0,28
275,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5402783238319924,1.0050365442278861,0.6187717112051895,"['APC2', 'SMAD2', 'CDKN1A', 'MAP2K1', 'TGFB2', 'JUN', 'BAD', 'GADD45A', 'PTGS2', 'TGFBR1', 'MAPK8', 'TBK1', 'MSH3', 'AKT2', 'POLK', 'RAF1', 'EXOC2', 'MAPK3']",0.9999812599146137,0,0,18
276,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5402783238319924,1.0050365442278861,0.6187717112051895,"['IDI1', 'FDPS', 'PRKAB2', 'PRKAA1', 'SEC24A', 'MDH1', 'PRKAG2', 'MED15', 'YY1', 'ACLY', 'SQLE', 'GPAM', 'SCD', 'SCAP', 'PRKACA', 'ATF6', 'LDLR', 'SEC31A']",0.9999812599146137,0,0,18
277,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5405176899553308,1.0702460850111857,0.658445265884066,"['RAB5B', 'PDCD6IP', 'RRAS2', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,5
278,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5405176899553308,1.0702460850111857,0.658445265884066,"['EIF2S3', 'EIF3I', 'EIF3G', 'EIF3C', 'EIF3A']",0.9999812599146137,0,0,5
279,Endometrial cancer WP4155,0.5471526831771452,1.0022984882514414,0.6044134385794226,"['APC2', 'CDKN1A', 'MAP2K1', 'PDPK1', 'BAD', 'GADD45A', 'ILK', 'PIK3R1', 'FOXO3', 'FGF2', 'AKT2', 'GRB2', 'POLK', 'CTNNA2', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,16
280,miRNA regulation of DNA damage response WP1530,0.5471526831771452,1.0022984882514414,0.6044134385794226,"['CDKN1A', 'GADD45A', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CCND3', 'CCNB1', 'CDK6', 'CDK5', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A', 'ATR']",0.9999812599146137,0,0,16
281,Endochondral Ossification with Skeletal Dysplasias WP4808,0.550569985165951,1.0090270041869935,0.6021885276540483,"['HDAC4', 'TGFB2', 'CHST11', 'SPP1', 'ENPP1', 'SOX9', 'PRKACA', 'CALM1', 'FGF2', 'RUNX2', 'BMPR1A']",0.9999812599146137,0,0,11
282,Endochondral Ossification WP474,0.550569985165951,1.0090270041869935,0.6021885276540483,"['HDAC4', 'TGFB2', 'CHST11', 'SPP1', 'ENPP1', 'SOX9', 'PRKACA', 'CALM1', 'FGF2', 'RUNX2', 'BMPR1A']",0.9999812599146137,0,0,11
283,Metabolic reprogramming in colon cancer WP4290,0.550569985165951,1.0090270041869935,0.6021885276540483,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'TKT', 'GAPDH', 'PSPH', 'GLS']",0.9999812599146137,0,0,11
284,Alzheimer's disease WP2059,0.5521176182060397,0.9958754722584264,0.5915442334730086,"['BAD', 'ITPR1', 'ADAM10', 'PSEN1', 'VMP1', 'PPP3CB', 'NCSTN', 'GRIN2A', 'PPP3CC', 'CDK5', 'CAPN2', 'APBB1', 'PLCB1', 'CALM1', 'ATF6', 'PLCB2', 'GAPDH', 'MAPK3', 'CDK5R1']",0.9999812599146137,0,0,19
285,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.555106361051051,0.998803970816888,0.5878915646178129,"['GRIA1', 'CDKN1A', 'MAP2K1', 'JUN', 'CBL', 'PPP2CA', 'MAPK8', 'DVL1', 'NEFL', 'NEFM', 'GRB2', 'PFN1', 'RAF1', 'NCK1']",0.9999812599146137,0,0,14
286,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.555106361051051,0.998803970816888,0.5878915646178129,"['ITGB1', 'SMARCAL1', 'CDKN1A', 'PTPRO', 'ILK', 'PARVA', 'CD2AP', 'LRP6', 'CDH2', 'MYH9', 'FYN', 'SYNPO', 'VCL', 'NCK1']",0.9999812599146137,0,0,14
287,Pancreatic adenocarcinoma pathway WP4263,0.5566484114616949,0.9912469955903783,0.5806937587660521,"['SMAD2', 'CDKN1A', 'MAP2K1', 'TGFB2', 'CHUK', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3R1', 'TGFBR1', 'IKBKB', 'TIAM1', 'MAPK8', 'CDK6', 'RPS6KB1', 'AKT2', 'POLK', 'RAF1', 'PAK3', 'PAK2', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,22
288,Fatty Acid Biosynthesis WP357,0.5600076641654607,1.0273899033297529,0.5956856070147055,"['PECR', 'ACLY', 'PC', 'SCD', 'ECH1', 'ACSL5']",0.9999812599146137,0,0,6
289,Hedgehog Signaling Pathway WP4249,0.5617466532329414,1.0050243623149457,0.5796018971670632,"['CSNK1G3', 'GRK3', 'SMURF1', 'GPR161', 'SPOP', 'FBXL17', 'SPOPL', 'ARRB1', 'PRKACA']",0.9999812599146137,0,0,9
290,Development and heterogeneity of the ILC family WP3893,0.562905925813577,1.100808769979685,0.6325717890140898,"['BCL11B', 'RORA', 'AHR']",0.9999812599146137,0,0,3
291,Dopamine metabolism WP2436,0.562905925813577,1.100808769979685,0.6325717890140898,"['PPP2CA', 'MAOB', 'PRKACA']",0.9999812599146137,0,0,3
292,Transcriptional cascade regulating adipogenesis WP4211,0.562905925813577,1.100808769979685,0.6325717890140898,"['CEBPA', 'KLF5', 'KLF15']",0.9999812599146137,0,0,3
293,Neural Crest Differentiation WP2064,0.5676186287667813,0.9877834144321358,0.5593871942280614,"['NOTCH2', 'ITGB1', 'HDAC4', 'HDAC3', 'CTBP2', 'HDAC8', 'FGF2', 'HDAC9', 'HDAC7', 'CDH6', 'CDH2', 'MPZ', 'DVL1', 'TCF4', 'SOX9']",0.9999812599146137,0,0,15
294,Glioblastoma signaling pathways WP2261,0.5738813482309356,0.9805387386945759,0.5445251413083462,"['MAP2K3', 'PDGFRA', 'CDKN1A', 'MAP2K1', 'PDPK1', 'CDKN2A', 'PIK3R1', 'PIK3C2A', 'FOXO3', 'CBL', 'PIK3C2B', 'CDK6', 'AKT2', 'NF1', 'EP300', 'ATM', 'MDM4', 'GRB2', 'RAF1', 'MAP2K5', 'MAPK3']",0.9999812599146137,0,0,21
295,MAPK pathway in congenital thyroid cancer WP4928,0.5821685373214627,1.0273752012882447,0.55580514510892,"['MAP2K1', 'JUN', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,4
296,NAD+ metabolism WP3644,0.5821685373214627,1.0273752012882447,0.55580514510892,"['NMNAT1', 'NMNAT3', 'SIRT7', 'SIRT2']",0.9999812599146137,0,0,4
297,SARS coronavirus and innate immunity WP4912,0.5821685373214627,1.0273752012882447,0.55580514510892,"['TBK1', 'DDX58', 'TYK2', 'JAK1']",0.9999812599146137,0,0,4
298,Ras signaling WP4223,0.5910337681073276,0.9721968682678676,0.5112609559469259,"['RAB5B', 'SHC3', 'RASAL1', 'RASAL2', 'PIK3R1', 'PLD2', 'RAP1B', 'IKBKB', 'GRIN2A', 'MAPK8', 'RASSF5', 'AKT2', 'ABL1', 'PRKACA', 'PAK3', 'PAK2', 'MAPK3', 'PDGFRA', 'NTRK2', 'MAP2K1', 'PLA2G12A', 'CHUK', 'BAD', 'INSR', 'PLA2G4B', 'RRAS2', 'KSR2', 'GAB2', 'GNG13', 'TIAM1', 'RASA1', 'RASA2', 'NF1', 'GRB2', 'RAF1', 'RGL1', 'CALM1', 'EXOC2', 'ARF6']",0.9999812599146137,0,0,39
299,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5974791383637122,0.9670499724539173,0.4980654632150398,"['THRB', 'MAZ', 'CREM', 'ATP1A3', 'RORA', 'ECE1', 'HDAC9', 'HSPD1', 'GJA1', 'PRKAR2A', 'EP300', 'TPPP', 'PKNOX1', 'PRKACA', 'YWHAG', 'CHRNB2', 'GABRA1', 'NTRK2', 'CPT1A', 'JUN', 'TACR1', 'HADHB', 'HADHA', 'TF', 'BHLHE40', 'SP3', 'GAPDH', 'SLC25A4', 'CC2D1A']",0.9999812599146137,0,0,29
300,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['H2AFY2', 'H2AFX', 'H2AFV', 'MAPK3', 'EZH2']",0.9999812599146137,0,0,5
301,Monoamine Transport WP727,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['UNC13B', 'TDO2', 'ADORA2A', 'MAPK14', 'AGT']",0.9999812599146137,0,0,5
302,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['MAP2K1', 'MAPKAPK2', 'ITPR1', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,5
303,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['ATF1', 'MAP2K1', 'RPS6KA5', 'MAPKAPK2', 'MAPK3']",0.9999812599146137,0,0,5
304,TYROBP causal network in microglia WP3945,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['MAF', 'FKBP15', 'CREB3L2', 'SPP1', 'TGFBR1']",0.9999812599146137,0,0,5
305,Vitamin D in inflammatory diseases WP4482,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['MAP2K3', 'IKBKB', 'MAP3K1', 'CHUK', 'MAPK14']",0.9999812599146137,0,0,5
306,Zinc homeostasis WP3529,0.5977919014106079,0.9878162106350026,0.5082438636882826,"['SLC30A7', 'SLC39A6', 'SLC39A11', 'SLC39A7', 'SLC39A1']",0.9999812599146137,0,0,5
307,Proteasome Degradation WP183,0.6001718359761335,0.9629878869448183,0.4916431342402167,"['H2AFX', 'UCHL1', 'PSMB4', 'PSMC5', 'PSMA4', 'PSMB5', 'PSMC6', 'UBB', 'PSMC3', 'PSMB3', 'PSMC4', 'PSMD2', 'PSME3', 'PSMD3', 'PSMD1']",0.9999812599146137,0,0,15
308,Amyotrophic lateral sclerosis (ALS) WP2447,0.6036979809385392,0.9630475678581026,0.4860320384754527,"['GRIA1', 'PPP3CB', 'DAXX', 'PPP3CC', 'BAD', 'DERL1', 'NEFL', 'NEFM', 'MAPK14']",0.9999812599146137,0,0,9
309,Neural Crest Cell Migration in Cancer WP4565,0.6036979809385392,0.9630475678581026,0.4860320384754527,"['NTRK2', 'TIAM1', 'JUN', 'SORT1', 'KIDINS220', 'AKT2', 'PIK3R4', 'PAK3', 'PAK2']",0.9999812599146137,0,0,9
310,Head and Neck Squamous Cell Carcinoma WP4674,0.6104680918867609,0.9554795807190893,0.4715571230974924,"['NOTCH2', 'CDKN1A', 'PRKAA1', 'MAML1', 'PDPK1', 'CDKN2A', 'MAPKAP1', 'RPS6', 'KEAP1', 'PIK3R1', 'RPTOR', 'CDK6', 'RHEB', 'AKT2', 'CSMD3', 'NFE2L2']",0.9999812599146137,0,0,16
311,Notch Signaling Pathway Netpath WP61,0.6118745566694611,0.9538029901226027,0.46853472592465717,"['NOTCH2', 'SPEN', 'CDKN1A', 'MAML1', 'FHL1', 'PSEN1', 'PIK3R1', 'NCSTN', 'ITCH', 'HEY1', 'EP300', 'CIR1', 'MAML3']",0.9999812599146137,0,0,13
312,Selenium Micronutrient Network WP15,0.6118745566694611,0.9538029901226027,0.46853472592465717,"['GPX3', 'INSR', 'DIO2', 'HBA1', 'PTGS2', 'SOD2', 'SELENOI', 'SELENOS', 'RFK', 'PRDX1', 'SELENOP', 'PNPO', 'LDLR']",0.9999812599146137,0,0,13
313,Focal Adhesion WP306,0.6182472005093402,0.9597041764810171,0.46148997291338145,"['ITGB1', 'SHC3', 'ROCK1', 'LAMA4', 'PDGFB', 'ILK', 'PIK3R1', 'ACTB', 'THBS4', 'THBS3', 'RAP1B', 'PPP1CC', 'CCND3', 'MAPK8', 'AKT2', 'SPP1', 'CAPN2', 'ITGB8', 'FLNB', 'FYN', 'PAK3', 'PAK2', 'MAPK3', 'PDGFRA', 'JUN', 'MAP2K1', 'PDPK1', 'BAD', 'TNK2', 'PARVA', 'VEGFD', 'VAV2', 'PPP1CA', 'RAPGEF1', 'ZYX', 'ITGA7', 'GRB2', 'RAF1', 'PPP1R12B', 'VCL']",0.9999812599146137,0,0,40
314,"GPCRs, Class A Rhodopsin-like WP455",0.6193750019020654,0.9509833283418189,0.45556321019241736,"['GPR27', 'OPRD1', 'GPR39', 'CHRM3', 'RABGAP1', 'CHRM1', 'HTR1F', 'CHRM5', 'GPR63', 'RRH', 'GPR83', 'ADRB1', 'ADRA2C', 'SSTR3', 'LTB4R', 'ADORA2A', 'GPR161', 'FSHR', 'GPER1', 'ACKR4']",0.9999812599146137,0,0,20
315,Calcium Regulation in the Cardiac Cell WP536,0.6214526082058628,0.9552869558655213,0.45442582536360543,"['CHRM3', 'GNAZ', 'RGS17', 'CAMK2D', 'CHRM1', 'CHRM5', 'ITPR1', 'GNAI3', 'CACNA1A', 'ADRB1', 'ARRB1', 'CACNA1E', 'ADCY5', 'GJA1', 'RGS2', 'GRK4', 'PRKAR2A', 'ANXA6', 'PRKACA', 'CAMK2G', 'RGS6', 'YWHAG', 'KCNJ3', 'ATP2B1', 'ATP1B1', 'GNG13', 'CACNB1', 'PKIB', 'STIM2', 'PRKD1', 'CASQ1', 'CALM1']",0.9999812599146137,0,0,32
316,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6220662837265558,0.9460370517251148,0.4490919493894441,"['ITGB1', 'ACTB', 'CACNB1', 'CACNB2', 'GJA1', 'SGCD', 'CACNB4', 'CDH2', 'LMNA', 'ITGB8', 'ITGA7', 'DMD', 'CTNNA2', 'CACNG2']",0.9999812599146137,0,0,14
317,Endothelin Pathways WP2197,0.6230372321775789,0.9461385130836761,0.44766449062268365,"['MAP2K1', 'ADRB1', 'ECE1', 'RAF1', 'PLCB1', 'CALM1', 'GNG13']",0.9999812599146137,0,0,7
318,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6230372321775789,0.9461385130836761,0.44766449062268365,"['RPTOR', 'BAD', 'RHEB', 'GRB10', 'PIK3R1', 'FOXO3', 'ATG13']",0.9999812599146137,0,0,7
319,PPAR signaling pathway WP3942,0.625971450280638,0.9415613516178184,0.4410749005425983,"['CYP27A1', 'CPT1A', 'FABP3', 'SCP2', 'PDPK1', 'SCD', 'ILK', 'ACSL5', 'SORBS1', 'CPT1C', 'PPARA']",0.9999812599146137,0,0,11
320,Effects of nitric oxide WP1995,0.6271579527703206,1.28425851434701,0.5991796093271082,['HBA1'],0.9999812599146137,0,0,1
321,Gene regulatory network modelling somitogenesis  WP2854,0.6271579527703206,1.28425851434701,0.5991796093271082,['EPHA4'],0.9999812599146137,0,0,1
322,Macrophage markers WP4146,0.6271579527703206,1.28425851434701,0.5991796093271082,['CD83'],0.9999812599146137,0,0,1
323,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.6271579527703206,1.28425851434701,0.5991796093271082,['AGT'],0.9999812599146137,0,0,1
324,Steroid Biosynthesis WP496,0.6271579527703206,1.28425851434701,0.5991796093271082,['HSD17B1'],0.9999812599146137,0,0,1
325,Aspirin and miRNAs WP4707,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['PPARA', 'PTGS2']",0.9999812599146137,0,0,2
326,Bile acids synthesis and enterohepatic circulation  WP4389,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['LDLR', 'MAPK3']",0.9999812599146137,0,0,2
327,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['DHCR24', 'LBR']",0.9999812599146137,0,0,2
328,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['TCF4', 'RUNX2']",0.9999812599146137,0,0,2
329,Disorders of Folate Metabolism and Transport WP4259,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['SLC46A1', 'ALDH1L1']",0.9999812599146137,0,0,2
330,Disorders of the Krebs cycle WP4236,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['PDHX', 'DHTKD1']",0.9999812599146137,0,0,2
331,Dual hijack model of Vif in HIV infection WP3300,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['UBB', 'RUNX1']",0.9999812599146137,0,0,2
332,Glial Cell Differentiation WP2276,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['CNP', 'TPPP']",0.9999812599146137,0,0,2
333,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['BLVRB', 'JAK1']",0.9999812599146137,0,0,2
334,Ketogenesis and Ketolysis WP4742,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['SLC2A1', 'SLC25A20']",0.9999812599146137,0,0,2
335,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['ITGB1', 'ZEB2']",0.9999812599146137,0,0,2
336,Mevalonate pathway WP3963,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['FDPS', 'ACAT2']",0.9999812599146137,0,0,2
337,Supression of HMGB1 mediated inflammation by THBD WP4479,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['IKBKB', 'CHUK']",0.9999812599146137,0,0,2
338,Urea cycle and related diseases WP4571,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['SLC25A15', 'SLC25A13']",0.9999812599146137,0,0,2
339,Valproic acid pathway WP3871,0.6272424831726028,1.0273605150214593,0.4791836258498624,"['HADHB', 'HADHA']",0.9999812599146137,0,0,2
340,Bladder cancer WP2828,0.6337435930587387,0.9338088026964975,0.4259203115141639,"['CDKN1A', 'MAP2K1', 'RPS6KA5', 'CDKN2A', 'DAPK2', 'PIK3R1', 'RAF1', 'HBEGF']",0.9999812599146137,0,0,8
341,Fatty acid beta-oxidation WP143,0.6337435930587387,0.9338088026964975,0.4259203115141639,"['HADHB', 'HADHA', 'ACADVL', 'CPT1A', 'ACSL5', 'SLC25A20', 'CRAT', 'DLD']",0.9999812599146137,0,0,8
342,Homologous recombination WP186,0.6342700394993673,0.9631070566138986,0.4384838482442303,"['RAD52', 'ATM', 'RAD54B']",0.9999812599146137,0,0,3
343,Hypertrophy Model WP516,0.6342700394993673,0.9631070566138986,0.4384838482442303,"['JUND', 'ADAM10', 'HBEGF']",0.9999812599146137,0,0,3
344,Mammalian disorder of sexual development WP4842,0.6342700394993673,0.9631070566138986,0.4384838482442303,"['RBFOX2', 'FGF9', 'SOX9']",0.9999812599146137,0,0,3
345,RAS and bradykinin pathways in COVID-19 WP4969,0.6342700394993673,0.9631070566138986,0.4384838482442303,"['ROCK1', 'SERPING1', 'AGT']",0.9999812599146137,0,0,3
346,Hepatitis B infection WP4666,0.6356431844706388,0.9474117843947527,0.42928924176631944,"['CDKN1A', 'PIK3R1', 'IKBKB', 'MAPK8', 'TBK1', 'AKT2', 'CREB3L2', 'EP300', 'MAP3K7', 'JAK1', 'MAPK3', 'MAP2K3', 'SMAD2', 'MAP2K1', 'TGFB2', 'JUN', 'MAP3K1', 'ATP6AP1', 'CHUK', 'DDX58', 'BAD', 'NFATC3', 'TYK2', 'MAPK14', 'TGFBR1', 'DDB1', 'CREB3', 'VDAC3', 'GRB2', 'TAB2', 'RAF1']",0.9999812599146137,0,0,31
347,Ciliopathies WP4803,0.6384676372664958,0.9515071593576686,0.42692631456837343,"['CEP104', 'C2CD3', 'IFT172', 'CEP120', 'CEP164', 'PIK3R4', 'LRRC6', 'PKD2', 'CCDC28B', 'FLCN', 'IFT52', 'ARL13B', 'TBC1D32', 'TMEM67', 'KIAA0753', 'POC1B', 'NPHP4', 'ZNF423', 'PIBF1', 'BBS5', 'CEP290', 'TAPT1', 'CEP78', 'DYNC2H1', 'BBS2', 'IQCB1', 'CFAP52', 'USP9X', 'DNAAF5', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'ICK', 'ARL2BP', 'WDR60', 'TMEM237', 'GPR161', 'NME9', 'ALMS1', 'ANKS6', 'WDPCP', 'CCDC65', 'SDCCAG8']",0.9999812599146137,0,0,43
348,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.6424966873737784,0.9338798614160932,0.41314249072946807,"['SETX', 'MORC3', 'AEBP2', 'EZH2']",0.9999812599146137,0,0,4
349,Overview of interferons-mediated signaling pathway WP4558,0.6424966873737784,0.9338798614160932,0.41314249072946807,"['IFNLR1', 'PIK3R1', 'TYK2', 'JAK1']",0.9999812599146137,0,0,4
350,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6424966873737784,0.9338798614160932,0.41314249072946807,"['DDR1', 'ANXA5', 'NRF1', 'NFE2L2']",0.9999812599146137,0,0,4
351,Spinal Cord Injury WP2431,0.6461546973681331,0.9335947071796128,0.4077160582018642,"['RTN4R', 'EPHA4', 'SEMA6A', 'GADD45A', 'OMG', 'XYLT1', 'MIF', 'TACR1', 'FOXO3', 'PTGS2', 'LTB4R', 'EFNB2', 'NR4A1', 'GJA1', 'C5', 'CHST11', 'PLXNA2', 'SOX9', 'ROS1', 'MAPK3']",0.9999812599146137,0,0,20
352,TLR4 Signaling and Tolerance WP3851,0.6507935000182158,0.9171620325982742,0.39397877457456293,"['IKBKB', 'TBK1', 'CHUK', 'TAB2', 'MAP3K7']",0.9999812599146137,0,0,5
353,Regulation of toll-like receptor signaling pathway WP1449,0.6539872332453225,0.9295283606511654,0.3947404374557983,"['MAP2K3', 'USP7', 'MAP2K1', 'JUN', 'CHUK', 'PIK3R1', 'MAPK14', 'RNF41', 'IKBKB', 'MAPK8', 'TBK1', 'RNF216', 'AKT2', 'SPP1', 'SARM1', 'TAB2', 'TMED7', 'ZMYND11', 'MAP3K7', 'CTNNAL1', 'MAPK3']",0.9999812599146137,0,0,21
354,Cannabinoid receptor signaling WP3869,0.6588533955658765,0.9063309534340052,0.37817042793161193,"['MAPK8', 'ADORA2A', 'AHR', 'PRKACA', 'MAPK14', 'MAPK3']",0.9999812599146137,0,0,6
355,Ethanol effects on histone modifications WP3996,0.6588533955658765,0.9063309534340052,0.37817042793161193,"['HDAC4', 'AHCY', 'HDAC3', 'HDAC8', 'HDAC9', 'HDAC7']",0.9999812599146137,0,0,6
356,Pathways Regulating Hippo Signaling WP4540,0.664690797113578,0.9203286506713849,0.37589288002967225,"['SMAD2', 'PDGFRA', 'NTRK2', 'PRKAB2', 'PRKAA1', 'INSR', 'GNAI3', 'PRKAG2', 'CDH8', 'CDH6', 'LATS1', 'CDH4', 'CDH2', 'CDH20', 'PRKAR2A', 'CDH12', 'PRKACA', 'PLCB1', 'PLCB2']",0.9999812599146137,0,0,19
357,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6665904493132432,0.8987375772226699,0.36450948388269283,"['IKBKB', 'HSP90AA1', 'CHUK', 'CARD9', 'ERBIN', 'NOD1', 'AAMP']",0.9999812599146137,0,0,7
358,Prostaglandin Synthesis and Regulation WP98,0.6665904493132432,0.8987375772226699,0.36450948388269283,"['HSD11B1', 'CBR1', 'ANXA5', 'ANXA6', 'PTGFRN', 'SOX9', 'PTGS2']",0.9999812599146137,0,0,7
359,Complement system WP2806,0.6810656976901132,0.8887809315113803,0.34137764959905587,"['PRNP', 'C5', 'C1S', 'C1QBP', 'GNAI3', 'SPP1', 'SERPING1', 'CD59', 'PRKACA']",0.9999812599146137,0,0,9
360,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6903658938259758,0.9031907142928431,0.3346624535949218,"['PDGFRA', 'MAP2K1', 'SHC3', 'PDPK1', 'BAD', 'RPS6', 'PDGFB', 'RRAS2', 'NRG2', 'PIK3R1', 'FOXO3', 'FGF2', 'RPS6KB1', 'AKT2', 'NF1', 'GRB2', 'RAF1', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,19
361,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['PLA2G4B', 'PRXL2B', 'PTGS2', 'PTGR2']",0.9999812599146137,0,0,4
362,Kallmann's Syndrome WP5074,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['ANOS1', 'GNRH1', 'FRS2', 'GRB2']",0.9999812599146137,0,0,4
363,Methionine De Novo and Salvage Pathway WP3580,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['MSRA', 'AHCY', 'AMD1', 'MSRB3']",0.9999812599146137,0,0,4
364,Microglia Pathogen Phagocytosis Pathway WP3937,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['PIK3C3', 'PIK3R1', 'PIK3C2A', 'VAV2']",0.9999812599146137,0,0,4
365,Pregnane X receptor pathway WP2876,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['HSP90AA1', 'PSMC5', 'NCOA3', 'CYP3A5']",0.9999812599146137,0,0,4
366,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6967727268843542,0.8559670781893004,0.30925747697201916,"['TBK1', 'DDX58', 'TYK2', 'JAK1']",0.9999812599146137,0,0,4
367,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6970489339002084,0.8560057239960648,0.30893217836865083,"['ADRB1', 'ADRA2C', 'ADCY5']",0.9999812599146137,0,0,3
368,Overview of nanoparticle effects WP3287,0.6970489339002084,0.8560057239960648,0.30893217836865083,"['CCND3', 'PTGS2', 'NFRKB']",0.9999812599146137,0,0,3
369,Serotonin and anxiety WP3947,0.6970489339002084,0.8560057239960648,0.30893217836865083,"['GABRA1', 'PLCD4', 'GRM1']",0.9999812599146137,0,0,3
370,EPO Receptor Signaling WP581,0.6991131689734084,0.8559284116331096,0.3063732826748637,"['MAP2K1', 'RASA1', 'GRB2', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,5
371,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6991131689734084,0.8559284116331096,0.3063732826748637,"['PRKAA1', 'MDH1', 'GOT2', 'SLC2A1', 'SIRT2']",0.9999812599146137,0,0,5
372,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7005444990074869,0.8801967263505726,0.3132597181111455,"['IKBKB', 'MAPK8', 'TBK1', 'TKFC', 'MAP3K1', 'CHUK', 'DDX58', 'DHX58', 'MAPK14', 'MAP3K7', 'TANK', 'ATG5']",0.9999812599146137,0,0,12
373,p53 transcriptional gene network WP4963,0.7005444990074869,0.8801967263505726,0.3132597181111455,"['PIDD1', 'CDKN1A', 'PRKAB2', 'ZMAT3', 'GADD45A', 'ADGRB1', 'SLC2A1', 'SLC7A11', 'POLK', 'ACAD11', 'CPT1C', 'CX3CL1']",0.9999812599146137,0,0,12
374,Fluoropyrimidine Activity WP1601,0.702691666773841,0.8558897243107769,0.30198963088967223,"['SMUG1', 'UCK2', 'UCK1', 'DPYS', 'ABCC5', 'GGH']",0.9999812599146137,0,0,6
375,Lung fibrosis WP3624,0.702691666773841,0.8558897243107769,0.30198963088967223,"['RTEL1', 'ELN', 'PDGFB', 'SPP1', 'FGF2', 'NFE2L2']",0.9999812599146137,0,0,6
376,Photodynamic therapy-induced unfolded protein response WP3613,0.702691666773841,0.8558897243107769,0.30198963088967223,"['PPP1R15A', 'EDEM1', 'UBE2E1', 'DNAJB9', 'ATF6', 'NFE2L2']",0.9999812599146137,0,0,6
377,G Protein Signaling Pathways WP35,0.7028459387883553,0.898355351846859,0.31677587166590815,"['GNAZ', 'PDE1C', 'PDE1A', 'ITPR1', 'GNAI3', 'ADCY5', 'GNG13', 'AKAP12', 'AKAP10', 'PPP3CC', 'AKAP11', 'PRKAR2A', 'AKAP9', 'ARHGEF1', 'PRKD1', 'PDE7B', 'PRKACA', 'PDE7A', 'CALM1', 'PDE8A', 'KCNJ3']",0.9999812599146137,0,0,21
378,ATR Signaling WP3875,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['RAD9A', 'ATR']",0.9999812599146137,0,0,2
379,Biomarkers for urea cycle disorders WP4583,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['GATM', 'GPT']",0.9999812599146137,0,0,2
380,"Degradation pathway of sphingolipids, including diseases WP4153",0.7036966017458218,0.8560443490701002,0.3008208147650096,"['HEXB', 'NEU1']",0.9999812599146137,0,0,2
381,Heme Biosynthesis WP561,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['UROD', 'UROS']",0.9999812599146137,0,0,2
382,IL1 and megakaryocytes in obesity WP2865,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['TIMP2', 'HBEGF']",0.9999812599146137,0,0,2
383,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['MYEF2', 'AKT2']",0.9999812599146137,0,0,2
384,Trans-sulfuration pathway WP2333,0.7036966017458218,0.8560443490701002,0.3008208147650096,"['DNMT1', 'AHCY']",0.9999812599146137,0,0,2
385,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7065255424622723,0.8782266400464438,0.3050923550920263,"['JUN', 'CTBP2', 'RYK', 'CHD8', 'SERPINF1', 'CSNK2A2', 'SENP2', 'LRP6', 'CCND3', 'DVL1', 'ROR1', 'WNT2', 'EZH2']",0.9999812599146137,0,0,13
386,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.715236700647453,0.9235038084874864,0.3095046743965328,"['ITGB1', 'CDKN1A', 'CHRM1', 'HSP90AB1', 'CAB39L', 'SLC2A1', 'HIF3A', 'PIK3C2A', 'FGF2', 'PIK3C2B', 'RPTOR', 'IKBKB', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'CREB3L2', 'ITGB8', 'JAK1', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'PDPK1', 'RPS6', 'PPP2R5D', 'PPP2R5C', 'CREB3', 'AKT1S1', 'ITGA7', 'RAF1', 'PFKFB4', 'PRKAA1', 'PHLPP1', 'LAMA4', 'PDGFB', 'PIK3R4', 'PIK3R1', 'FOXO3', 'THBS4', 'THBS3', 'PPP2CA', 'SPP1', 'MAPK3', 'BAD', 'INSR', 'VEGFD', 'GNG13', 'EFNA3', 'PIK3IP1', 'RPS6KB1', 'RHEB', 'PPP2R2B', 'GRB2']",0.9999812599146137,0,0,54
387,Phosphodiesterases in neuronal function WP4222,0.7254559878963359,0.8556959756206866,0.2746397931908027,"['GRIA1', 'GUCY1A2', 'GRIN2A', 'ADORA2A', 'PDE1C', 'PDE1A', 'PDE3A', 'PDE7B', 'PDE7A', 'PDE8A', 'ADCY5']",0.9999812599146137,0,0,11
388,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7301011200814564,0.8556571633494711,0.2691659852189442,"['IKBKB', 'CAMK2D', 'MAPK8', 'JUN', 'SP3', 'TYK2', 'PLCB1', 'MAPK14', 'PLCB2', 'CAMK2G', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,12
389,Composition of Lipid Particles WP3601,0.7316666280203531,0.8560829534280862,0.26746624965022664,['LDLR'],0.9999812599146137,0,0,1
390,FTO Obesity Variant Mechanism WP3407,0.7316666280203531,0.8560829534280862,0.26746624965022664,['FTO'],0.9999812599146137,0,0,1
391,Platelet-mediated interactions with vascular and circulating cells WP4462,0.7316666280203531,0.8560829534280862,0.26746624965022664,['TGFB2'],0.9999812599146137,0,0,1
392,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.7316666280203531,0.8560829534280862,0.26746624965022664,['EPHA4'],0.9999812599146137,0,0,1
393,Corticotropin-releasing hormone signaling pathway WP2355,0.7333641116391194,0.8716554163955758,0.27031164020422926,"['GNAZ', 'HSP90AA1', 'MAP2K1', 'JUND', 'ARRB1', 'ECE1', 'MAPK14', 'RAP1B', 'NR4A1', 'GJA1', 'GRK3', 'MAPK8', 'STAR', 'FOSB', 'TCF4', 'RAF1', 'JUNB', 'MAPK3']",0.9999812599146137,0,0,18
394,Wnt signaling pathway and pluripotency WP399,0.738210889063421,0.870751049004889,0.2642953544709653,"['JUN', 'CTBP2', 'LRRK2', 'PPP2R2A', 'PPM1J', 'PPP2R5C', 'LRP6', 'PPP2CA', 'PTPA', 'CCND3', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'DVL1', 'EP300', 'PRKD1', 'MAP3K7', 'WNT2', 'LDLR']",0.9999812599146137,0,0,19
395,Toll-like Receptor Signaling Pathway WP75,0.739175582557038,0.8555794761392178,0.25857305085225396,"['MAP2K3', 'MAP2K1', 'JUN', 'CHUK', 'PIK3R1', 'MAPK14', 'IKBKB', 'MAPK8', 'TBK1', 'AKT2', 'SPP1', 'TAB2', 'MAP3K7', 'MAPK3']",0.9999812599146137,0,0,14
396,IL17 signaling pathway WP2112,0.7425450741635334,0.8107580982531517,0.24133974480393477,"['IKBKB', 'MAP3K7', 'IL17RC', 'MAP3K14', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,6
397,Cardiac Progenitor Differentiation WP2406,0.7425835912504254,0.8023489932885906,0.2387949740589239,"['PDGFRA', 'LIN28B', 'THY1', 'MAPK14', 'FGF2']",0.9999812599146137,0,0,5
398,White fat cell differentiation WP4149,0.7425835912504254,0.8023489932885906,0.2387949740589239,"['CEBPA', 'KLF5', 'RORA', 'ZNF423', 'KLF15']",0.9999812599146137,0,0,5
399,Androgen receptor signaling pathway WP138,0.7429088902200897,0.8699346703823838,0.25852880862703087,"['TGIF1', 'CDKN1A', 'DAXX', 'JUN', 'ROCK1', 'NCOA3', 'LIMK2', 'RNF6', 'EFCAB6', 'PIK3R1', 'NR2C2', 'PIAS2', 'ETV5', 'RUNX2', 'PRDX1', 'ZNF318', 'RACK1', 'EP300', 'STUB1', 'RAD9A']",0.9999812599146137,0,0,20
400,Melatonin metabolism and effects WP3298,0.7438080841384129,0.81686323346275,0.24176883187448756,"['PER2', 'CYP1B1', 'ADRB1', 'ECE1', 'CALM1', 'CLOCK', 'ARNTL']",0.9999812599146137,0,0,7
401,Constitutive Androstane Receptor Pathway WP2875,0.7448511444875042,0.7900408769973988,0.2327230416059379,"['PTPA', 'HSP90AA1', 'NCOA6', 'CYP3A5']",0.9999812599146137,0,0,4
402,Mitochondrial Gene Expression WP391,0.7448511444875042,0.7900408769973988,0.2327230416059379,"['MYEF2', 'NRF1', 'POLRMT', 'TFB1M']",0.9999812599146137,0,0,4
403,Triacylglyceride synthesis WP325,0.7448511444875042,0.7900408769973988,0.2327230416059379,"['GPAM', 'MOGAT1', 'AGPS', 'AGPAT4']",0.9999812599146137,0,0,4
404,Vitamin B12 metabolism WP1533,0.7448511444875042,0.7900408769973988,0.2327230416059379,"['INSR', 'HBA1', 'SOD2', 'LDLR']",0.9999812599146137,0,0,4
405,Osteoblast differentiation WP4787,0.7474667568365543,0.869193504900895,0.252992196177487,"['NOTCH2', 'PIK3R4', 'PIK3R1', 'PIK3C2A', 'MAPK14', 'FGF2', 'SMAD5', 'RUNX2', 'PIK3C2B', 'LRP6', 'FGF5', 'MAPK8', 'FGF9', 'HEY1', 'PIK3C3', 'SOX9', 'PRKD1', 'WNT2', 'MAPK4', 'BMPR1A', 'MAPK3']",0.9999812599146137,0,0,21
406,Integrated Cancer Pathway WP1971,0.7484436747881587,0.8251238146427612,0.23908732265659097,"['ATF1', 'SMAD2', 'CDKN1A', 'POU2F1', 'BAD', 'ATM', 'JAK1', 'CDC25B', 'ATR']",0.9999812599146137,0,0,9
407,Biomarkers for pyrimidine metabolism disorders WP4584,0.7512697157212022,0.7703246579017977,0.2203055722750078,"['DPYS', 'CKB', 'DHODH']",0.9999812599146137,0,0,3
408,PPAR-alpha pathway WP2878,0.7512697157212022,0.7703246579017977,0.2203055722750078,"['CPT1A', 'SCP2', 'PPARA']",0.9999812599146137,0,0,3
409,PI3K-Akt signaling pathway WP4172,0.7573046518017056,0.905107853805287,0.2516106247843822,"['ITGB1', 'CDKN1A', 'CHRM1', 'HSP90AB1', 'PPP2R2A', 'FGF2', 'RPTOR', 'IKBKB', 'FGF5', 'GYS1', 'CCND3', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'CREB3L2', 'ITGB8', 'JAK1', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'CHUK', 'PDPK1', 'RPS6', 'PPP2R5D', 'PPP2R5C', 'CREB3', 'ITGA7', 'SGK1', 'RAF1', 'PRKAA1', 'PHLPP1', 'LAMA4', 'PDGFB', 'PIK3R1', 'FOXO3', 'THBS4', 'THBS3', 'PPP2CA', 'SPP1', 'THEM4', 'MAPK3', 'NTRK2', 'BAD', 'INSR', 'VEGFD', 'GNG13', 'EFNA3', 'CDK6', 'RPS6KB1', 'RHEB', 'PPP2R2B', 'COL9A3', 'GRB2']",0.9999812599146137,0,0,54
410,Autosomal recessive Osteopetrosis pathways WP4788,0.7665848016234683,0.7336756591048437,0.19501829167562415,"['IKBKB', 'PLEKHM1']",0.9999812599146137,0,0,2
411,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7665848016234683,0.7336756591048437,0.19501829167562415,"['JUN', 'MAPK3']",0.9999812599146137,0,0,2
412,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7665848016234683,0.7336756591048437,0.19501829167562415,"['YAP1', 'SPARC']",0.9999812599146137,0,0,2
413,Serotonin and anxiety-related events WP3944,0.7665848016234683,0.7336756591048437,0.19501829167562415,"['NLGN1', 'PLCD4']",0.9999812599146137,0,0,2
414,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7677584689274101,0.8368541166832465,0.22116388033835319,"['MAP2K3', 'MAP2K1', 'JUN', 'PDPK1', 'RPS6', 'GNAI3', 'PIK3R1', 'MAPK14', 'RAP1B', 'CCND3', 'RPS6KB1', 'RAF1', 'PLCB1', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,15
415,Male infertility WP4673,0.7680947122205594,0.8553069111171026,0.2256660829639403,"['SLC46A1', 'PACRG', 'CCNT2', 'INSR', 'UBR2', 'PEX10', 'AHR', 'SOD2', 'CLU', 'ETV5', 'PUM2', 'ARNTL', 'CDK9', 'CCNA1', 'MSH4', 'EP300', 'ATM', 'TRIP13', 'CLOCK', 'RAG1', 'NFE2L2']",0.9999812599146137,0,0,21
416,mRNA Processing WP411,0.7743134826138417,0.8732494850580532,0.2233584181703901,"['SF3B4', 'TMED10', 'SFSWAP', 'DDX1', 'CELF2', 'SRSF1', 'PRPF8', 'POLR2A', 'CLP1', 'PCBP2', 'DHX15', 'SPOP', 'DHX38', 'SNRPD3', 'SRSF10', 'RBM5', 'SRPK2', 'CPSF4', 'RBM39', 'RNGTT', 'NONO', 'PRPF40A', 'DICER1', 'SUPT5H', 'HNRNPAB', 'PRPF4', 'PRPF18', 'PRPF3', 'CD2BP2', 'SRSF4', 'SRSF7', 'SRSF9']",0.9999812599146137,0,0,32
417,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7773059325200756,0.7812656926975674,0.19681744595002582,"['LDHA', 'PKM', 'IGFBP3', 'SLC2A1', 'ARNT', 'PTGS2', 'HK1']",0.9999812599146137,0,0,7
418,Glycerophospholipid Biosynthetic Pathway WP2533,0.7783973823274298,0.7701396348012889,0.19293392652027158,"['GPAM', 'PTPMT1', 'IPMK', 'AGPS', 'CEPT1', 'PI4K2A']",0.9999812599146137,0,0,6
419,Nanoparticle-mediated activation of receptor signaling WP2643,0.7783973823274298,0.7701396348012889,0.19293392652027158,"['ITGB1', 'MAPK8', 'MAP2K1', 'GRB2', 'MAPK14', 'RAF1']",0.9999812599146137,0,0,6
420,7-oxo-C and 7beta-HC pathways WP5064,0.7812301989889812,0.7550730359257797,0.18641652628332486,"['HSD11B1', 'CYP27A1', 'ACOT9', 'SCP2', 'ACOT11']",0.9999812599146137,0,0,5
421,Oncostatin M Signaling Pathway WP2374,0.7855174992043045,0.8137102436399667,0.1964398597878999,"['MAP2K1', 'JUND', 'RPS6', 'TYK2', 'PIK3R1', 'MAPK14', 'MAPK8', 'GRB2', 'RAF1', 'JUNB', 'LDLR', 'JAK1', 'MAPK3']",0.9999812599146137,0,0,13
422,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7855174992043045,0.8137102436399667,0.1964398597878999,"['ITGB1', 'YAP1', 'CHUK', 'BAD', 'PIK3R1', 'MAPK14', 'IKBKB', 'MAPK8', 'GRB14', 'RASA1', 'GRB2', 'NCK1', 'MAPK3']",0.9999812599146137,0,0,13
423,Heart Development WP1591,0.7868680136337142,0.7335327045471973,0.17582394032068027,"['HEY1', 'BHLHE40', 'NFATC3', 'BMPR1A']",0.9999812599146137,0,0,4
424,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7868680136337142,0.7335327045471973,0.17582394032068027,"['UGCG', 'B3GALT1', 'KDSR', 'SGPP2']",0.9999812599146137,0,0,4
425,Retinoblastoma gene in cancer WP2446,0.7954413382712445,0.8230083998597483,0.18835220112815187,"['CDKN1A', 'DNMT1', 'FAF1', 'RPA2', 'SMARCA2', 'SMC2', 'CDC25B', 'NPAT', 'ANLN', 'CCND3', 'CCNB1', 'CDK6', 'MCM3', 'ABL1', 'ZNF655', 'SKP2', 'RAF1']",0.9999812599146137,0,0,17
426,Differentiation of white and brown adipocyte WP2895,0.797388150345575,0.7002219674610337,0.1585398496317928,"['CEBPA', 'ZNF423', 'SMAD5']",0.9999812599146137,0,0,3
427,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.797388150345575,0.7002219674610337,0.1585398496317928,"['PPARA', 'PTGR2', 'LTB4R']",0.9999812599146137,0,0,3
428,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8053608872526037,0.7776963180188987,0.16834387395664258,"['SMAD2', 'TGFB2', 'MAP2K1', 'GRB2', 'MAP3K9', 'LBR', 'SYNE1', 'ADCY5', 'MAPK3', 'PLEC']",0.9999812599146137,0,0,10
429,ESC Pluripotency Pathways WP3931,0.8059076311029769,0.828815562975714,0.17884691496209357,"['ACVR1', 'MAP2K3', 'PDGFRA', 'MAP2K1', 'JUN', 'PDGFB', 'FGF2', 'SMAD5', 'LRP6', 'FGF5', 'FGF9', 'AKT2', 'SELENOP', 'DVL1', 'GRB2', 'RAF1', 'WNT2', 'MAP2K5', 'MAPK4', 'BMPR1A', 'JAK1']",0.9999812599146137,0,0,21
430,Acetylcholine Synthesis WP528,0.8068867615686266,0.6419951729686243,0.13775415024498647,['PCYT1A'],0.9999812599146137,0,0,1
431,Cytokines and Inflammatory Response WP530,0.8068867615686266,0.6419951729686243,0.13775415024498647,['HLA-DRB1'],0.9999812599146137,0,0,1
432,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.8068867615686266,0.6419951729686243,0.13775415024498647,['CDKN1A'],0.9999812599146137,0,0,1
433,Metabolism of alpha-linolenic acid WP4586,0.8068867615686266,0.6419951729686243,0.13775415024498647,['PTGS2'],0.9999812599146137,0,0,1
434,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.8068867615686266,0.6419951729686243,0.13775415024498647,['HEY1'],0.9999812599146137,0,0,1
435,PTF1A related regulatory pathway WP4147,0.8068867615686266,0.6419951729686243,0.13775415024498647,['PROX1'],0.9999812599146137,0,0,1
436,Small Ligand GPCRs WP247,0.8068867615686266,0.6419951729686243,0.13775415024498647,['S1PR3'],0.9999812599146137,0,0,1
437,The alternative pathway of fetal androgen synthesis WP4524,0.8068867615686266,0.6419951729686243,0.13775415024498647,['STAR'],0.9999812599146137,0,0,1
438,Vitamin D Metabolism WP1531,0.8068867615686266,0.6419951729686243,0.13775415024498647,['CYP27A1'],0.9999812599146137,0,0,1
439,AGE/RAGE pathway WP2324,0.8069240351066027,0.7895891091157363,0.16938719393039833,"['IKBKB', 'SMAD2', 'MAP2K1', 'MAPK8', 'JUN', 'CHUK', 'ROCK1', 'INSR', 'EZR', 'RAF1', 'MAPK14', 'MAPK3']",0.9999812599146137,0,0,12
440,Hematopoietic Stem Cell Differentiation WP2849,0.8152237041441476,0.7130499627143922,0.14567091623090542,"['THRB', 'HMGN5', 'MXI1', 'FOSB', 'RUNX1']",0.9999812599146137,0,0,5
441,Oxidative Stress WP408,0.8152237041441476,0.7130499627143922,0.14567091623090542,"['GPX3', 'MAPK14', 'SOD2', 'JUNB', 'NFE2L2']",0.9999812599146137,0,0,5
442,Pre-implantation embryo WP3527,0.8152237041441476,0.7130499627143922,0.14567091623090542,"['H2AFY2', 'KHSRP', 'FOSB', 'ATP1A1', 'HNRNPAB']",0.9999812599146137,0,0,5
443,Cysteine and methionine catabolism WP4504,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['AHCY', 'SUOX']",0.9999812599146137,0,0,2
444,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['CD274', 'TGFB2']",0.9999812599146137,0,0,2
445,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['FDPS', 'IDI1']",0.9999812599146137,0,0,2
446,Nanoparticle triggered regulated necrosis WP2513,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['MAPK8', 'FTL']",0.9999812599146137,0,0,2
447,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['RNASEH2C', 'DDX58']",0.9999812599146137,0,0,2
448,TCA cycle in senescence WP5050,0.8175044336950675,0.6418991416309013,0.12934200480668911,"['PDP2', 'MDH1']",0.9999812599146137,0,0,2
449,Glucocorticoid Receptor Pathway WP2880,0.8288622949168581,0.7547438330170778,0.14166635901209773,"['RGS2', 'HSP90AA1', 'JUN', 'NAV3', 'ABHD2', 'AMIGO2', 'BHLHE40', 'SPRY1', 'PTGS2', 'SLC19A2']",0.9999812599146137,0,0,10
450,Breast cancer pathway WP4262,0.83366210961993,0.8231808122016905,0.1497589004560804,"['NOTCH2', 'CDKN1A', 'SHC3', 'PIK3R1', 'FGF2', 'LRP6', 'FGF5', 'FGF9', 'HEY1', 'AKT2', 'DVL1', 'POLK', 'WNT2', 'MAPK3', 'APC2', 'MAP2K1', 'JUN', 'GADD45A', 'NCOA3', 'CSNK2A2', 'CDK6', 'RPS6KB1', 'ATM', 'GRB2', 'RAF1', 'ATR']",0.9999812599146137,0,0,26
451,Cholesterol Biosynthesis Pathway WP197,0.8361109460586457,0.6418030587603971,0.11487887366303452,"['FDPS', 'IDI1', 'SQLE']",0.9999812599146137,0,0,3
452,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8361109460586457,0.6418030587603971,0.11487887366303452,"['ABCD2', 'ABCD3', 'PPARA']",0.9999812599146137,0,0,3
453,Peptide GPCRs WP24,0.8448373460104948,0.6754503708936771,0.1138884706141567,"['OPRD1', 'FSHR', 'TAC4', 'TACR1', 'SSTR3']",0.9999812599146137,0,0,5
454,Apoptosis WP254,0.8482550819193894,0.7641595859194283,0.12576071125883206,"['HRK', 'DFFB', 'HELLS', 'JUN', 'MAP3K1', 'CHUK', 'CDKN2A', 'BAD', 'PIK3R1', 'CFLAR', 'IKBKB', 'IRF2', 'CASP2', 'NFKBIE']",0.9999812599146137,0,0,14
455,Wnt Signaling Pathway WP363,0.8501221259976612,0.7331029185867896,0.11903777860613647,"['GJA1', 'MAPK8', 'CDK6', 'RYK', 'DVL1', 'ROR1', 'TCF4', 'MAP3K7', 'PI4K2A', 'LRP6']",0.9999812599146137,0,0,10
456,Pyrimidine metabolism WP4022,0.8508164060670627,0.7825193600233782,0.12642297699978583,"['PRIM2', 'PNPT1', 'DPYS', 'CTPS1', 'DHODH', 'POLA2', 'UCK2', 'UCK1', 'POLR2A', 'POLR3B', 'POLR2C', 'CMPK1', 'ENPP1', 'CMPK2', 'POLR3G', 'POLR2G', 'POLR3H', 'POLR2J']",0.9999812599146137,0,0,18
457,Complement and Coagulation Cascades WP558,0.8541647624682988,0.6417069243156199,0.10115301553031004,"['C1S', 'CLTC', 'SERPING1', 'CLU']",0.9999812599146137,0,0,4
458,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8541647624682988,0.6417069243156199,0.10115301553031004,"['IKBKB', 'CHUK', 'RASSF5', 'CBLB']",0.9999812599146137,0,0,4
459,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8541647624682988,0.6417069243156199,0.10115301553031004,"['YY1', 'CEBPA', 'PTPN1', 'CHUK']",0.9999812599146137,0,0,4
460,One-carbon metabolism and related pathways WP3940,0.8544724670673443,0.7078878615501492,0.11133023049260066,"['AHCYL1', 'PCYT1A', 'GPX3', 'DNMT3A', 'CEPT1', 'BCAT1', 'SOD2', 'BCAT2']",0.9999812599146137,0,0,8
461,Allograft Rejection WP2328,0.8581443363100655,0.6909027046013347,0.10569634738871508,"['PECR', 'PDGFRA', 'TUBA1B', 'C5', 'LRRK2', 'CSNK2A2', 'HLA-DRB1']",0.9999812599146137,0,0,7
462,Notch Signaling WP268,0.8581443363100655,0.6909027046013347,0.10569634738871508,"['NOTCH2', 'NCSTN', 'CTBP2', 'MAML1', 'DVL1', 'PSEN1', 'MAML3']",0.9999812599146137,0,0,7
463,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8582231004632696,0.570517405817835,0.08722708477430921,"['MYRIP', 'SYTL3']",0.9999812599146137,0,0,2
464,GDNF/RET signaling axis WP4830,0.8582231004632696,0.570517405817835,0.08722708477430921,"['SPRY1', 'FAT4']",0.9999812599146137,0,0,2
465,GPR40 Pathway WP3958,0.8582231004632696,0.570517405817835,0.08722708477430921,"['PLCB1', 'PLCB2']",0.9999812599146137,0,0,2
466,Leptin Insulin Overlap WP3935,0.8582231004632696,0.570517405817835,0.08722708477430921,"['PDPK1', 'INSR']",0.9999812599146137,0,0,2
467,"NAD metabolism, sirtuins and aging WP3630",0.8582231004632696,0.570517405817835,0.08722708477430921,"['FOXO3', 'ROS1']",0.9999812599146137,0,0,2
468,RalA downstream regulated genes WP2290,0.8582231004632696,0.570517405817835,0.08722708477430921,"['EXOC8', 'EXOC2']",0.9999812599146137,0,0,2
469,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8582231004632696,0.570517405817835,0.08722708477430921,"['RAD21', 'ANAPC2']",0.9999812599146137,0,0,2
470,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8593715327042931,0.8012820512820513,0.12143744615922136,"['NOTCH2', 'SPARC', 'TUSC3', 'EIF5A2', 'PIK3R1', 'NR2C2', 'LRP6', 'MAPK8', 'CDH2', 'AKT2', 'WNT2', 'MAPK3', 'MAP2K3', 'SMAD2', 'MAP2K1', 'TGFB2', 'NUBPL', 'PROX1', 'MAPK14', 'TGFBR1', 'ZEB2', 'CLDN12', 'GRB2', 'RAF1', 'EZH2']",0.9999812599146137,0,0,25
471,ACE Inhibitor Pathway WP554,0.8610248672035294,0.5135425046929472,0.07684233721689661,['AGT'],0.9999812599146137,0,0,1
472,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.8610248672035294,0.5135425046929472,0.07684233721689661,['SMAD5'],0.9999812599146137,0,0,1
473,Caloric restriction and aging WP4191,0.8610248672035294,0.5135425046929472,0.07684233721689661,['PRKAB2'],0.9999812599146137,0,0,1
474,EDA signaling in hair follicle development WP3930,0.8610248672035294,0.5135425046929472,0.07684233721689661,['SOSTDC1'],0.9999812599146137,0,0,1
475,Fluoroacetic acid toxicity WP4966,0.8610248672035294,0.5135425046929472,0.07684233721689661,['ALDH3A2'],0.9999812599146137,0,0,1
476,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.8610248672035294,0.5135425046929472,0.07684233721689661,['ALDH1L1'],0.9999812599146137,0,0,1
477,Peroxiredoxin 2 induced ovarian failure WP4873,0.8610248672035294,0.5135425046929472,0.07684233721689661,['STAR'],0.9999812599146137,0,0,1
478,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8610248672035294,0.5135425046929472,0.07684233721689661,['TGFB2'],0.9999812599146137,0,0,1
479,Serine Metabolism WP4688,0.8610248672035294,0.5135425046929472,0.07684233721689661,['PSPH'],0.9999812599146137,0,0,1
480,22q11.2 copy number variation syndrome WP4657,0.8664571219194543,0.7734320531410265,0.11086580417232342,"['RTN4R', 'RTL10', 'CBX5', 'HDAC3', 'OAT', 'TANGO2', 'CHRD', 'KLHL22', 'MED15', 'MALT1', 'ARNTL', 'POLR2A', 'THAP7', 'DGCR6L', 'DROSHA', 'RAF1', 'TNPO1', 'DEPDC5', 'DGCR2']",0.9999812599146137,0,0,19
481,Transcription factor regulation in adipogenesis WP3599,0.8682658491927898,0.5923716744752431,0.08367684308453857,"['CEBPA', 'MAPK8', 'INSR']",0.9999812599146137,0,0,3
482,Urea cycle and metabolism of amino groups WP497,0.8682658491927898,0.5923716744752431,0.08367684308453857,"['GATM', 'OAT', 'CKB']",0.9999812599146137,0,0,3
483,Glycosylation and related congenital defects WP4521,0.8704103613287255,0.6416107382550336,0.08904947443071172,"['DPAGT1', 'TUSC3', 'PMM2', 'MGAT2', 'ALG1']",0.9999812599146137,0,0,5
484,DNA IR-damage and cellular response via ATR WP4016,0.8796911707368238,0.7460713761198414,0.09563469338835688,"['SMARCAL1', 'UPF1', 'POLN', 'ABRAXAS1', 'CEP164', 'H2AFX', 'XPA', 'RPA2', 'PALB2', 'SEM1', 'RAD52', 'HERC2', 'UIMC1', 'ATM', 'RAD9A', 'ATR']",0.9999812599146137,0,0,16
485,Cytoplasmic Ribosomal Proteins WP477,0.8803245148521998,0.7654181920585751,0.09756377926062114,"['RPL4', 'RPS9', 'RPL31', 'RPLP1', 'RPS5', 'RPLP0', 'RPS6', 'MRPL19', 'RPL23A', 'RPL8', 'RPS6KA3', 'RPS6KA6', 'RPS16', 'RPS6KB1', 'RPL27A', 'RPL14', 'RPS20', 'RPS11', 'RPL18', 'RPS12']",0.9999812599146137,0,0,20
486,Differentiation Pathway WP2848,0.8804190957063819,0.603896308926147,0.07691056700470414,"['TF', 'PDGFB', 'FGF2', 'WNT2']",0.9999812599146137,0,0,4
487,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8804190957063819,0.603896308926147,0.07691056700470414,"['SMAD2', 'TGFB2', 'RAF1', 'TGFBR1']",0.9999812599146137,0,0,4
488,Cell cycle WP179,0.8813903430045927,0.7726869707851222,0.09755534860261969,"['SMAD2', 'TGFB2', 'CDKN1A', 'GADD45A', 'CDKN2A', 'CDC14B', 'CDC25B', 'MAD2L2', 'CCNA1', 'CCND3', 'CCNB1', 'CDK6', 'STAG2', 'RAD21', 'ABL1', 'MCM3', 'EP300', 'ATM', 'SKP2', 'YWHAG', 'ANAPC2', 'ATR']",0.9999812599146137,0,0,22
489,Neural Crest Cell Migration during Development WP4564,0.8847639907535875,0.6415145005370569,0.078543408741977,"['TIAM1', 'JUN', 'AKT2', 'PIK3R4', 'PAK3', 'PAK2']",0.9999812599146137,0,0,6
490,Cell Differentiation - Index expanded WP2023,0.8904578466693667,0.5134120171673819,0.05956581275050182,"['RUNX2', 'EZH2']",0.9999812599146137,0,0,2
491,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.8904578466693667,0.5134120171673819,0.05956581275050182,"['CD81', 'SPP1']",0.9999812599146137,0,0,2
492,Galanin receptor pathway WP4970,0.8904578466693667,0.5134120171673819,0.05956581275050182,"['YAP1', 'CDKN1A']",0.9999812599146137,0,0,2
493,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8904578466693667,0.5134120171673819,0.05956581275050182,"['PFKFB4', 'LDHA']",0.9999812599146137,0,0,2
494,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8904578466693667,0.5134120171673819,0.05956581275050182,"['TCF4', 'DKK3']",0.9999812599146137,0,0,2
495,Oxysterols derived from cholesterol WP4545,0.8923181607867521,0.6109939277724513,0.06961208247939724,"['CYP27A1', 'ACOT9', 'SCP2', 'ACOT11', 'CYP7B1']",0.9999812599146137,0,0,5
496,Hippo-Yap signaling pathway WP4537,0.8947117870567908,0.5500019165165395,0.06118971423138534,"['LATS1', 'STK38L', 'MAP4K4']",0.9999812599146137,0,0,3
497,Nanomaterial induced apoptosis WP2507,0.8947117870567908,0.5500019165165395,0.06118971423138534,"['ENDOG', 'HTRA2', 'CFLAR']",0.9999812599146137,0,0,3
498,Purinergic signaling WP4900,0.8947117870567908,0.5500019165165395,0.06118971423138534,"['GNAZ', 'ADORA2A', 'GNAI3']",0.9999812599146137,0,0,3
499,Copper homeostasis WP3286,0.8973913711339861,0.6414182111200645,0.06944198864706673,"['PRNP', 'JUN', 'COX17', 'ADAM10', 'ADAM9', 'COMMD1', 'FOXO3']",0.9999812599146137,0,0,7
500,Estrogen metabolism WP697,0.8999884774427437,0.42790739250916243,0.0450900219941097,['CYP1B1'],0.9999812599146137,0,0,1
501,Inflammatory Response Pathway WP453,0.8999884774427437,0.42790739250916243,0.0450900219941097,['THBS3'],0.9999812599146137,0,0,1
502,Liver X receptor pathway WP2874,0.8999884774427437,0.42790739250916243,0.0450900219941097,['SCD'],0.9999812599146137,0,0,1
503,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.8999884774427437,0.42790739250916243,0.0450900219941097,['LDLR'],0.9999812599146137,0,0,1
504,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.8999884774427437,0.42790739250916243,0.0450900219941097,['JUN'],0.9999812599146137,0,0,1
505,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.8999884774427437,0.42790739250916243,0.0450900219941097,['CAMK2D'],0.9999812599146137,0,0,1
506,Sulfation Biotransformation Reaction WP692,0.8999884774427437,0.42790739250916243,0.0450900219941097,['PAPSS2'],0.9999812599146137,0,0,1
507,Unfolded protein response WP4925,0.9024610130273749,0.5702868730243932,0.05852842120264479,"['PPP1R15A', 'CASP2', 'ATF6', 'NFE2L2']",0.9999812599146137,0,0,4
508,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9046572730561246,0.6596153107843513,0.06609286761988795,"['PPP1R15A', 'PPP1CC', 'PPP1R3F', 'MAPK8', 'PPP1R14B', 'PPP1R9A', 'PPP1R12B', 'ATF6', 'PPP1CA']",0.9999812599146137,0,0,9
509,Nucleotide Excision Repair WP4753,0.9046572730561246,0.6596153107843513,0.06609286761988795,"['CUL4A', 'DDB1', 'XPA', 'RPA2', 'GTF2H1', 'ERCC6', 'MNAT1', 'RAD23B', 'CUL4B']",0.9999812599146137,0,0,9
510,Integrated breast cancer pathway WP1984,0.9069038694492317,0.7764946764946765,0.07587814496829805,"['ATF1', 'USP15', 'USP38', 'USP16', 'GDI1', 'MYCBP2', 'AHR', 'DHTKD1', 'IMPA1', 'ABL1', 'EP300', 'JAK1', 'SMAD2', 'JUN', 'CHUK', 'GADD45A', 'BAD', 'NCOA3', 'PPP4R3A', 'TGFBR1', 'CDC25B', 'HIPK2', 'ITPKC', 'RHEB', 'NF1', 'ATM', 'ZNF655', 'MAP3K13', 'BMPR1A', 'ATR']",0.9999812599146137,0,0,30
511,Intraflagellar transport proteins binding to dynein WP4532,0.9109490143681465,0.5831604636973764,0.05439041420712165,"['DYNC2H1', 'WDR60', 'IFT80', 'DYNLRB1', 'DYNLL2']",0.9999812599146137,0,0,5
512,Fatty acid transporters WP5061,0.9157646940123693,0.46668942645337497,0.041066724167741674,"['FABP3', 'ACSL5']",0.9999812599146137,0,0,2
513,"GPCRs, Class B Secretin-like WP334",0.9157646940123693,0.46668942645337497,0.041066724167741674,"['ADGRL2', 'ADGRL3']",0.9999812599146137,0,0,2
514,Omega-9 FA synthesis WP4724,0.9157646940123693,0.46668942645337497,0.041066724167741674,"['SCD', 'ELOVL6']",0.9999812599146137,0,0,2
515,Globo Sphingolipid Metabolism WP1424,0.916280472354334,0.5132814596189965,0.044877619110589316,"['GALNT2', 'FUT2', 'ST6GALNAC5']",0.9999812599146137,0,0,3
516,Immune response to tuberculosis WP4197,0.916280472354334,0.5132814596189965,0.044877619110589316,"['TYK2', 'IFIT1', 'JAK1']",0.9999812599146137,0,0,3
517,"Relationship between inflammation, COX-2 and EGFR WP4483",0.916280472354334,0.5132814596189965,0.044877619110589316,"['AKT2', 'PTGS2', 'MAPK3']",0.9999812599146137,0,0,3
518,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.916280472354334,0.5132814596189965,0.044877619110589316,"['IDH3G', 'OGDH', 'DLD']",0.9999812599146137,0,0,3
519,Toll-like Receptor Signaling related to MyD88 WP3858,0.916280472354334,0.5132814596189965,0.044877619110589316,"['IKBKB', 'TBK1', 'CHUK']",0.9999812599146137,0,0,3
520,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9182910233426226,0.6412254770223058,0.05465864940271862,"['HELLS', 'CDKN1A', 'JUND', 'RPS6KB1', 'ANXA5', 'ABL1', 'RNF7', 'PAK2', 'HSPD1']",0.9999812599146137,0,0,9
521,Non-small cell lung cancer WP4255,0.9183777567252162,0.6903204438188292,0.058778351240658104,"['CDKN1A', 'MAP2K1', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3R1', 'FOXO3', 'CDK6', 'RASSF5', 'AKT2', 'GRB2', 'POLK', 'RAF1', 'MAPK3']",0.9999812599146137,0,0,14
522,Vitamin D-sensitive calcium signaling in depression WP4698,0.9192432049513419,0.5920432950508139,0.04985273970003741,"['CYP27A1', 'GRIN2A', 'CHRM1', 'ITPR1', 'ATP2B1', 'NFE2L2']",0.9999812599146137,0,0,6
523,Wnt signaling in kidney disease WP4150,0.9208267031341909,0.5402152724807187,0.04455880432675506,"['MAPK8', 'DVL1', 'WNT2', 'LRP6']",0.9999812599146137,0,0,4
524,Cytosolic DNA-sensing pathway WP4655,0.92222618340544,0.621822741113445,0.050345733526137144,"['IKBKB', 'TBK1', 'CHUK', 'POLR3B', 'DDX58', 'POLR3G', 'POLR3H', 'ATG5']",0.9999812599146137,0,0,8
525,Prion disease pathway WP3995,0.9266866405751735,0.5577473008462212,0.04246677162944522,"['PRNP', 'RAD21', 'EP300', 'FYN', 'MAPK3']",0.9999812599146137,0,0,5
526,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.9280300577213929,0.36673945523503043,0.027392194205029224,['WNT2'],0.9999812599146137,0,0,1
527,Blood Clotting Cascade WP272,0.9280300577213929,0.36673945523503043,0.027392194205029224,['F8A1'],0.9999812599146137,0,0,1
528,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.9280300577213929,0.36673945523503043,0.027392194205029224,['ZYG11B'],0.9999812599146137,0,0,1
529,Adipogenesis WP236,0.9313991136784867,0.7118897873614854,0.050592156299733904,"['GDF10', 'WWTR1', 'CEBPA', 'MBNL1', 'CDKN1A', 'GADD45A', 'ASIP', 'NR2F1', 'RORA', 'AHR', 'MIF', 'KLF15', 'AGT', 'BSCL2', 'BMP3', 'KLF5', 'SCD', 'DVL1', 'LMNA', 'PPARA']",0.9999812599146137,0,0,20
530,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9337415256324079,0.48115105983364637,0.03298560835651952,"['ITGB1', 'PDGFRA', 'RUNX2']",0.9999812599146137,0,0,3
531,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9341344784345775,0.6034706198438538,0.041117392186169784,"['CYP27A1', 'IDI1', 'FDPS', 'MYLIP', 'SQLE', 'SCD', 'DHCR24', 'LBR']",0.9999812599146137,0,0,8
532,Eicosanoid Synthesis WP167,0.9354940345490778,0.42775393419170243,0.028522850503395692,"['PLA2G4B', 'PTGS2']",0.9999812599146137,0,0,2
533,Kennedy pathway from sphingolipids WP3933,0.9354940345490778,0.42775393419170243,0.028522850503395692,"['PCYT1A', 'CEPT1']",0.9999812599146137,0,0,2
534,Pyrimidine metabolism and related diseases WP4225,0.9354940345490778,0.42775393419170243,0.028522850503395692,"['DPYS', 'DHODH']",0.9999812599146137,0,0,2
535,Riboflavin and CoQ disorders WP5037,0.9354940345490778,0.42775393419170243,0.028522850503395692,"['SLC52A2', 'RFK']",0.9999812599146137,0,0,2
536,Chemokine signaling pathway WP3929,0.9375609513704573,0.7186601485653378,0.046334541165364417,"['MAP2K1', 'SHC3', 'CHUK', 'ROCK1', 'GNAI3', 'ARRB1', 'PIK3R1', 'FOXO3', 'CX3CL1', 'GNG13', 'VAV2', 'ADCY5', 'TIAM2', 'RAP1B', 'IKBKB', 'TIAM1', 'GRK4', 'AKT2', 'GRB2', 'RAF1', 'PLCB1', 'PLCB2', 'MAPK3']",0.9999812599146137,0,0,23
537,miRNA regulation of prostate cancer signaling pathways WP3981,0.9398978862784158,0.5344519015659955,0.03312748870619952,"['CDKN1A', 'MAP2K1', 'BAD', 'GRB2', 'RAF1']",0.9999812599146137,0,0,5
538,SARS-CoV-2 mitochondrial interactions WP5038,0.947784417464507,0.4528007070818668,0.0242828915551648,"['TBK1', 'DDX58', 'PHB2']",0.9999812599146137,0,0,3
539,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.947784417464507,0.4528007070818668,0.0242828915551648,"['RASA1', 'FYN', 'CALM1']",0.9999812599146137,0,0,3
540,Glutathione metabolism WP100,0.9482106035578731,0.3208635022794315,0.01706308652126489,['GPX3'],0.9999812599146137,0,0,1
541,Mitochondrial complex III assembly WP4921,0.9507836597478961,0.3948085176625949,0.01992548425729756,"['UQCC3', 'CYC1']",0.9999812599146137,0,0,2
542,Alpha 6 Beta 4 signaling pathway WP244,0.9587412902219852,0.466403162055336,0.019651435893387918,"['GRB2', 'PIK3R1', 'MAPK14', 'MAPK3']",0.9999812599146137,0,0,4
543,Glycerolipids and Glycerophospholipids WP4722,0.9590119068027211,0.42760039352472945,0.017895841156668625,"['PCYT1A', 'GPAM', 'AGPAT4']",0.9999812599146137,0,0,3
544,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9590119068027211,0.42760039352472945,0.017895841156668625,"['ZMAT3', 'EI24', 'ATM']",0.9999812599146137,0,0,3
545,Type II interferon signaling (IFNG) WP619,0.9590119068027211,0.42760039352472945,0.017895841156668625,"['IRF2', 'IFIT2', 'JAK1']",0.9999812599146137,0,0,3
546,Statin inhibition of cholesterol production WP430,0.9625718408133029,0.3665695892090742,0.013983374620585019,"['SQLE', 'LDLR']",0.9999812599146137,0,0,2
547,Hedgehog Signaling Pathway Netpath WP47,0.9627334057886409,0.28518220553618784,0.010830861606046594,['ARNTL'],0.9999812599146137,0,0,1
548,Non-homologous end joining WP438,0.9627334057886409,0.28518220553618784,0.010830861606046594,['XRCC6'],0.9999812599146137,0,0,1
549,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9640844688542598,0.5627322841355261,0.02058270137539215,"['NUBPL', 'NDUFAF7', 'NDUFAF4', 'NDUFS4', 'NDUFAF2', 'NDUFS2', 'NDUFAF3', 'TMEM186', 'FOXRED1']",0.9999812599146137,0,0,9
550,DNA Repair Pathways Full Network WP4946,0.9646671262347489,0.6828566288900881,0.024563844339670904,"['XRCC6', 'FANCM', 'MPG', 'H2AFX', 'XPA', 'RPA2', 'GTF2H1', 'FANCB', 'PALB2', 'TERF2', 'RAD23B', 'RAD54B', 'DDB1', 'CUL4A', 'SMUG1', 'RAD52', 'MSH3', 'ATM', 'POLK', 'ERCC6', 'MNAT1', 'FAN1', 'ATR', 'CUL4B']",0.9999812599146137,0,0,24
551,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9670529367173226,0.44607808817008565,0.014944526748271124,"['SMAD2', 'RAF1', 'TGFBR1', 'MCU']",0.9999812599146137,0,0,4
552,Gastric Cancer Network 2 WP2363,0.9679409332287168,0.4050527445525539,0.013198324888184705,"['AHCTF1', 'COL9A3', 'LBR']",0.9999812599146137,0,0,3
553,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9716197737254192,0.3420958512160229,0.009849189405226715,"['LRP6', 'RUNX1T1']",0.9999812599146137,0,0,2
554,FOXA2 pathway WP5066,0.973184336833156,0.25663716814159293,0.006975850604865186,['MLXIPL'],0.9999812599146137,0,0,1
555,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.973184336833156,0.25663716814159293,0.006975850604865186,['TULP3'],0.9999812599146137,0,0,1
556,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.973184336833156,0.25663716814159293,0.006975850604865186,['JAK1'],0.9999812599146137,0,0,1
557,NO metabolism in cystic fibrosis WP4947,0.973184336833156,0.25663716814159293,0.006975850604865186,['PRMT3'],0.9999812599146137,0,0,1
558,Apoptosis Modulation by HSP70 WP384,0.9785371155927175,0.320681330472103,0.006957682289864389,"['MAP3K1', 'CASP2']",0.9999812599146137,0,0,2
559,Ovarian infertility WP34,0.9785371155927175,0.320681330472103,0.006957682289864389,"['FSHR', 'ATM']",0.9999812599146137,0,0,2
560,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9838071174937975,0.30178616510982076,0.004926785880879203,"['CBX5', 'MBD2']",0.9999812599146137,0,0,2
561,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9838071174937975,0.30178616510982076,0.004926785880879203,"['BAD', 'MAPK14']",0.9999812599146137,0,0,2
562,Striated Muscle Contraction Pathway WP383,0.9838071174937975,0.30178616510982076,0.004926785880879203,"['TNNC2', 'DMD']",0.9999812599146137,0,0,2
563,miRNA targets in ECM and membrane receptors WP2911,0.9861164239000192,0.21381961204970054,0.0029893808580154255,['LAMA4'],0.9999812599146137,0,0,1
564,Omega-3/Omega-6 FA synthesis WP4723,0.9861164239000192,0.21381961204970054,0.0029893808580154255,['PLA2G4B'],0.9999812599146137,0,0,1
565,Mitochondrial CIV Assembly WP4922,0.9897992558874822,0.366229583620888,0.0037549988880931713,"['SURF1', 'COX17', 'CMC1', 'COX5A']",0.9999812599146137,0,0,4
566,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9900103716432629,0.19735132124512655,0.0019813795376461473,['BCL2L13'],0.9999812599146137,0,0,1
567,Myometrial relaxation and contraction pathways WP289,0.9921733893573491,0.5923749503207858,0.004654526527232394,"['ATF1', 'RGS17', 'JUN', 'CAMK2D', 'IGFBP3', 'ITPR1', 'ARRB1', 'ACTB', 'GNG13', 'ADCY5', 'PKIB', 'CREB3', 'GJA1', 'RGS2', 'GRK4', 'PRKAR2A', 'PRKD1', 'PRKACA', 'CALM1', 'CAMK2G', 'RGS6', 'YWHAG']",0.9999812599146137,0,0,22
568,DNA Replication WP466,0.9937376343358015,0.34174270889246733,0.0021468470148456186,"['PRIM2', 'POLA2', 'MCM3', 'RPA2']",0.9999812599146137,0,0,4
569,Vitamin A and carotenoid metabolism WP716,0.994703942516477,0.2957833687643186,0.0015706485270012766,"['RDH10', 'BCO2', 'BCO1']",0.9999812599146137,0,0,3
570,Oxidative phosphorylation WP623,0.9985516363291969,0.3413891872538489,0.0004948141183826135,"['ATP5F1A', 'NDUFS8', 'ATP6AP1', 'NDUFS7', 'NDUFS4', 'NDUFS2']",0.9999812599146137,0,0,6
571,Small cell lung cancer WP4658,0.9990994723694595,0.41374183445897855,0.0003727538165981804,"['ITGB1', 'IKBKB', 'CDKN1A', 'CDK6', 'CHUK', 'GADD45A', 'AKT2', 'LAMA4', 'POLK', 'PIK3R1', 'PTGS2']",0.9999812599146137,0,0,11
572,DNA Mismatch Repair WP531,0.9992811222664262,0.1220677061385026,8.778331244753651e-05,['RPA2'],0.9999812599146137,0,0,1
573,Base Excision Repair WP4752,0.9993449458363974,0.18301655426118946,0.00011992503886468525,"['SMUG1', 'MPG']",0.9999812599146137,0,0,2
574,Nonalcoholic fatty liver disease WP4396,0.9994061569152788,0.4965699050357988,0.00029497219645676455,"['CEBPA', 'PRKAB2', 'JUN', 'PRKAA1', 'INSR', 'PRKAG2', 'PIK3R1', 'ADIPOR2', 'COX5A', 'IKBKB', 'VMP1', 'MLXIPL', 'MAPK8', 'ITCH', 'NDUFS8', 'NDUFS7', 'AKT2', 'NDUFS4', 'NDUFS2', 'CYC1', 'PPARA']",0.9999812599146137,0,0,21
575,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9999812599146137,0.29464784073760153,5.52177743375484e-06,"['SURF1', 'ATP5F1A', 'NDUFS8', 'NDUFS7', 'COX17', 'NDUFS4', 'NDUFS2', 'SLC25A4', 'COX5A']",0.9999812599146137,0,0,9
